WO2013057883A1 - Drug container, and drug-filled container in which drug is sealed therein - Google Patents

Drug container, and drug-filled container in which drug is sealed therein Download PDF

Info

Publication number
WO2013057883A1
WO2013057883A1 PCT/JP2012/006203 JP2012006203W WO2013057883A1 WO 2013057883 A1 WO2013057883 A1 WO 2013057883A1 JP 2012006203 W JP2012006203 W JP 2012006203W WO 2013057883 A1 WO2013057883 A1 WO 2013057883A1
Authority
WO
WIPO (PCT)
Prior art keywords
drug
medicine
storage chamber
container according
chamber
Prior art date
Application number
PCT/JP2012/006203
Other languages
French (fr)
Japanese (ja)
Inventor
伸一 安井
Original Assignee
パナソニック株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2011269709A external-priority patent/JP2015002752A/en
Priority claimed from JP2011278118A external-priority patent/JP2015002754A/en
Application filed by パナソニック株式会社 filed Critical パナソニック株式会社
Publication of WO2013057883A1 publication Critical patent/WO2013057883A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10Bag-type containers
    • A61J1/12Bag-type containers with means for holding samples of contents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/1462Containers with provisions for hanging, e.g. integral adaptations of the container
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2093Containers having several compartments for products to be mixed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202Separating means
    • A61J1/2027Separating means having frangible parts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14Details; Accessories therefor
    • A61J1/20Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202Separating means
    • A61J1/2037Separating means having valve means

Definitions

  • the present invention relates to a medicine container and a medicine container containing the medicine.
  • a drug container used for infusion treatment is configured by flowing a drug from a drug supply port into a drug storage chamber.
  • an infusion needle is connected to the medicine supply port via a tube, and the infusion needle is inserted into the patient, whereby the medicine in the medicine storage chamber is administered to the patient (for example, see Patent Document 1 below).
  • the amount of medicine stored in the medicine storage room needs to be set to an appropriate amount depending on the physique and age of the patient. For this reason, in a drug room, for example, a drug required for each individual is aspirated by an injection needle from an individual drug bottle and injected into a drug storage chamber of a drug container for each individual. . That is, at this time, it takes a lot of work such as taking out the medicine bottle, sucking and injecting the injection needle, storing the medicine bottle, and discarding the injection needle.
  • an object of this invention is to provide the chemical
  • the drug container includes a drug storage chamber, a drug adjustment chamber, a drug adjustment path, a suction port, and an on-off valve.
  • the medicine storage chamber has a medicine supply port.
  • the medicine adjustment room adjusts the medicine stored in the medicine storage room and has a fixed shape.
  • the medicine adjustment path connects the medicine storage room and the medicine adjustment room.
  • the suction port is connected to the medicine adjustment chamber.
  • the on-off valve is provided in the medicine adjustment path.
  • the drug container includes a drug adjustment chamber, a drug administration port, and a drug stirring unit.
  • the drug adjustment chamber stores the solution.
  • the medicine storage chamber is connected to the medicine adjustment chamber via a medicine supply path and stores the medicine.
  • the drug administration port is connected to the drug adjustment room.
  • the drug stirring unit is connected to the drug adjusting chamber and can store a stirring bar therein.
  • the method of using the drug container includes a plurality of drug storage chambers, a plurality of drug supply passages connected to each of the plurality of drug storage chambers, and a drug connected to the plurality of drug supply paths via open / close valves.
  • the on-off valve switches the open / close state of each medicine storage chamber and medicine supply port in the order of (1) to (5) below.
  • (1) Closed state (2) First drug storage chamber and drug supply port open state (3) Second drug storage chamber and drug supply port open state (4) N (where N is 2 (Natural number above)
  • the drug storage chamber and the drug supply port are open (5) closed
  • the drug container of the present invention adjustment of the drug amount required for each individual, which differs depending on the patient's physique and age, is performed by moving some drugs to the drug adjustment room by opening the on-off valve. Therefore, workability can be improved as compared with the conventional case.
  • medical agent which concerns on Embodiment 1 of this invention The front view which shows the usage example of the container containing a chemical
  • medical agent of FIG. The front view which shows the container with a chemical
  • medical agent container of FIG. Schematic explaining the operation
  • the flowchart which shows the operation
  • the front view which shows the container with a chemical
  • (A)-(f) is a figure which shows the use procedure of the container containing a chemical
  • the flowchart which shows the usage method of the container with a chemical
  • a transparent medicine storage chamber 1 has a medicine supply port 2.
  • a transparent medicine adjustment chamber 4 is connected to the medicine storage chamber 1 via a medicine adjustment path 3.
  • a suction port 5 is connected to the medicine adjustment chamber 4.
  • an on-off valve 6 is provided in the medicine adjustment path 3.
  • the medicine storage chamber 1 has a cylindrical shape and is flexible.
  • the medicine adjustment chamber 4 is cylindrical and has a fixed shape.
  • the medicine adjustment chamber 4 is provided with an adjustment scale 7.
  • the front and back surfaces of the medicine storage chamber 1 and the medicine adjustment chamber 4 are covered with a transparent cover 8 having flexibility.
  • a medicine supply port 2 is provided outside the cover 8 on the first end side.
  • a hanging hole 9 for adjusting the medicine is provided on the first end side of the cover 8.
  • a hanging hole 10 at the time of drug administration is provided on the second end side of the cover 8 opposite to the first end.
  • a suction port 5 is provided on the side portion of the cover 8 so as to face the outside of the cover 8.
  • the medicine manufactured by the pharmaceutical company is in the direction of the medicine supply port 2 facing upward, as shown in FIG. It is stored inside. At this time, the on-off valve 6 is closed as shown in FIG. In addition, after the medicine 11 is supplied into the medicine storage chamber 1, the medicine supply port 2 is also closed. For this reason, the medicine 11 is enclosed in the medicine storage chamber 1, and is delivered to the hospital as a medicine-containing medicine container in this enclosed state.
  • the drug 11 is infused to the patient as follows. First, as shown in FIG. 2, for example, in a hospital room, a drug-containing drug container with the suspension hole 9 side at the time of drug adjustment facing upward is hung by the hook 12 at the portion of the suspension hole 9 at the time of drug adjustment.
  • the syringe 13 or the suction device 14 is inserted into the suction port 5. Thereafter, as shown in FIG. 2, the on-off valve 6 is opened. Next, the air in the medicine adjustment chamber 4 is aspirated by the syringe 13 or the aspirator 14. Then, the medicine 11 in the medicine storage chamber 1 moves into the medicine adjustment chamber 4 via the medicine adjustment path 3.
  • the amount of the medicine 11 remaining in the medicine storage chamber 1 is set according to the amount of movement of the medicine 11 to the medicine adjustment chamber 4. That is, the amount of the drug 11 remaining in the drug storage chamber 1 is set so that an appropriate amount of infusion can be performed according to the patient's physique and age.
  • the drug storage chamber 1 is filled with, for example, 1000 cc of the drug 11 and 150 cc is moved into the drug adjustment chamber 4 as described above, the drug storage chamber 1 has 850 cc. The drug 11 is stored.
  • the on-off valve 6 is closed, and then the above-described syringe 13 or suction device 14 is pulled out from the suction port 5. At this time, when the syringe 13 or the suction device 14 is pulled out from the suction port 5, the suction port 5 is automatically closed.
  • the suspension hole 10 at the time of drug administration is suspended from the hook 12 so that the suspension hole 10 side at the time of drug administration faces upward.
  • the infusion needle 16 is connected to the medicine supply port 2 via the tube 15, and in this state, the infusion needle 16 is inserted into the patient.
  • the medicine supply port 2 is in an open state. Therefore, in this state, if the on-off valve (not shown) interposed in the tube 15 is opened, the medicine 11 in the medicine storage chamber 1 is administered to the patient from the drip needle 16.
  • the amount of the drug 11 required for different individuals depending on the patient's physique and age is adjusted by opening the on-off valve 6. This can be done by moving some drugs 11 to the drug adjustment chamber 4. Therefore, workability can be improved as compared with the prior art. Further, as apparent from the above description, the adjusted medicine 11 is merely moved to the medicine adjustment chamber 4 and is not taken out of the medicine container of the present embodiment. Therefore, also from this point, it is possible to provide a drug container that is easy to handle and has high workability.
  • the adjusted medicine 11 is simply moved to the medicine adjustment chamber 4 and is not taken out of the medicine container, so that the handling thereof is extremely simple and has high workability. it can.
  • FIG. 4 shows the configuration of a medicine container according to Embodiment 2 of the present invention.
  • a sub-drug storage chamber 18 is connected to the drug storage chamber 1 via a rupture film 17 provided as a first communication portion. That is, another medicine 19 is stored in the auxiliary medicine storage chamber 18.
  • FIG. 5 shows the structure of the medicine container according to Embodiment 3 of the present invention.
  • a powdered drug 20 is stored in the drug storage chamber 1. Further, the medicine storage chamber 1 is provided with a rupture film 21 as a first communication portion. A liquid medicine 23 is stored in the secondary medicine storage chamber 22 connected via the rupture film 21. Further, the medicine storage chamber 1 is provided with a sub open / close valve 24 as a first communication portion.
  • a liquid medicine 26 is housed in the secondary medicine storage chamber 25 connected via the secondary opening / closing valve 24. For this reason, immediately before the drip, first, the rupture film 21 is broken to mix the drug 23 and the drug 20, and the sub-open / close valve 24 is opened to allow the drug 26 to flow into the drug storage chamber 1 and mix.
  • FIG. 6 shows the configuration of a medicine container according to Embodiment 4 of the present invention.
  • a suction member 27 is connected to the suction port 5.
  • FIG. 7 shows the structure of a medicine container according to Embodiment 5 of the present invention.
  • a secondary drug storage chamber 29 connected to the drug adjustment chamber 4 via a rupture film 28 provided as a second communication portion is provided.
  • the secondary drug storage chamber 29 has a drug as a neutralizing agent that neutralizes the drug 11 stored in the drug storage chamber 1 or a deactivating agent that detoxifies the drug 11 stored in the drug storage chamber 1. 30 is stored.
  • the medicine (for example, medicine 11) in the medicine storage chamber 1 is moved to the medicine adjustment chamber 4, no processing is performed.
  • a secondary drug storage chamber 29 connected to the drug adjustment chamber 4 via a rupture film 28 provided as a second communication portion, the inside of the drug storage chamber 1 is provided.
  • the medicine 30 stored in the auxiliary medicine storage chamber 29 is neutralized with the neutralizing agent that neutralizes the medicine stored in the medicine storage chamber 1 (for example, the medicine 11) or the medicine stored in the medicine storage chamber 1.
  • a medicine (for example, medicine 11) stored in the medicine storage chamber 1 can be neutralized or detoxified.
  • the drug (for example, drug 11) is a cancer therapeutic drug, it is very toxic, so the drug (for example, drug 11) stored in the drug storage chamber 1 is stored in the drug adjustment chamber 4. It is extremely useful in that it can be neutralized or detoxified after being transferred.
  • FIG. 8 shows the configuration of a medicine container according to Embodiment 6 of the present invention.
  • a gas-liquid separation membrane 31 is provided between the drug adjustment chamber 4 and the suction port 5.
  • the on-off valve 6 is opened.
  • the drug for example, the drug 11
  • the medicine in the medicine storage chamber 1 moves into the medicine adjustment room 4 via the medicine adjustment path 3
  • a small amount of the medicine for example, medicine 11
  • the drug will be atomized by negative pressure due to suction.
  • medical agent is used, there exists a possibility that the atomized trace amount chemical
  • FIG. As a result, there is a risk of touching a medical worker (for example, a nurse) who performs infusion or the like using this medicine container.
  • the drug for example, drug 11
  • a toxic drug for example, a drug used for instillation treatment of cancer
  • the air in the drug adjustment chamber 4 When performing the operation
  • a gas-liquid separation membrane 31 is provided between the drug adjustment chamber 4 and the suction port 5.
  • the atomized trace amount medicine for example, medicine 11
  • gas-liquid separation membrane 31 it is possible to prevent leakage of the atomized small amount of medicine (for example, medicine 11) to the outside. Therefore, it is possible to prevent the medical staff who performs intravenous infusion using this drug container from being violated by toxicity.
  • FIG. 9 shows the configuration of a medicine container according to Embodiment 9 of the present invention.
  • the medicine adjustment chamber 4 is provided with a medicine administration scale 32 for indicating the amount of medicine (for example, medicine 11) stored in the first medicine storage chamber 1.
  • the adjustment scale 7 is described so that the numbers increase sequentially from the opening / closing valve 6 side to the suction port 5 side. Yes.
  • the medicine container of the present embodiment is described such that the medicine administration scale 32 has a numerical value that decreases sequentially from the opening / closing valve 6 side to the suction port 5 side.
  • the adjustment scale 7 is moved from the medicine storage chamber 1 of the medicine (for example, medicine 11) into the medicine adjustment chamber 4. It shows the amount of movement.
  • the medicine administration scale 32 is a medicine (for example, medicine) stored in the medicine storage chamber 1 after the medicine (for example, medicine 11) is moved from the medicine storage room 1 into the medicine adjustment room 4. 11) is provided to show the quantity.
  • the specific example which concerns on this embodiment is demonstrated.
  • 400 cc medicine for example, medicine 11 is filled in the medicine storage chamber 1 in advance.
  • the medicine for example, medicine 11
  • the medicine is moved from the medicine storage chamber 1 into the medicine adjustment chamber 4 to the position of 250 cc (dotted line A in FIG. 9) of the medicine administration scale 32 in the medicine adjustment chamber 4.
  • 250 cc of medicine for example, medicine 11
  • the medicine storage room 1 in the medicine adjustment room 4, actually Is the state where 150cc has been moved.
  • the amount of the medicine (for example, medicine 11) in the medicine storage room 1 after the movement from the medicine storage room 1 into the medicine adjustment room 4 is determined by the medical worker (for example, nursing) Master) You don't have to do it yourself. That is, the medical staff can more easily adjust the amount of the medicine (for example, the medicine 11) in the medicine storage chamber 1 to the amount required for each patient by directly reading the medicine administration scale 32. Can be adjusted.
  • FIG. 10 shows a configuration of a medicine container according to Embodiment 8 of the present invention.
  • the present embodiment is different from the configuration of the seventh embodiment in that the inside of the medicine adjustment chamber 4 with the medicine administration scale 32 is evacuated. That is, in the medicine container of the present embodiment, the inside of the medicine adjustment chamber 4 is in a vacuum state in order to suck a part of the medicine 11 into the medicine adjustment chamber 4. Accordingly, even if the suction member 27 shown in FIG. 6 or the suction port 5 shown in FIG. 9 is not provided, an appropriate amount of medicine can be easily introduced into the medicine adjustment chamber 4 by operating the on-off valve 6. 11 can be moved.
  • FIG. 11 is a perspective view showing a medicine container according to the present embodiment.
  • FIG. 12 is a front view showing the medicine container according to the present embodiment.
  • the drug container 101 of the present embodiment is connected to a cylindrical drug storage chamber 103 for storing a solution 102 and a drug storage chamber 103 via a cylindrical drug supply path 104.
  • a flat bag-shaped drug storage chamber 106 storing the drug 105 and a drug supply port 107 connected to the first end side of the cylindrical drug storage chamber 103 are provided.
  • the medicine storage chamber 106 has a flat bag shape, and has flexibility to be freely deformed by being pressed from the outside.
  • the medicine storage chamber 103 is formed in a cylindrical shape having a fixed shape, it may be formed as a cylindrical member having flexibility.
  • the stirring unit 109 is connected.
  • the medicine stirring part 109 is transparent and cylindrical, has a regular shape, and the medicine storage chamber 103 side is open.
  • the drug container 101 according to the present embodiment is provided with an outer peripheral plane part 110 in the outer peripheral part of the drug storage chamber 103.
  • the outer peripheral plane part 110 is provided with a medicine storage chamber 106.
  • the outer peripheral flat part 110 is formed by bonding two flat bodies. Accordingly, the above-described cylindrical medicine supply path 104 is formed by covering the medicine storage chamber 106 and not sticking (non-adhering) a part of the two flat bodies.
  • the drug supply path 104 is provided with a rupture film 113 that separates the drug storage chamber 106 and the drug storage chamber 103.
  • a holding part 111 and a holding part 112 are provided on the medicine supply port 107 side and the medicine stirring part 109 side in the outer peripheral flat part 110, respectively.
  • the holding part 111 and the holding part 112 are configured by forming a through hole in the outer peripheral plane part 110.
  • the stirrer 108 of the drug container 101 of the present embodiment uses a bar magnet sealed with Teflon (registered trademark) or the like. In addition, a long and narrow cylindrical shape is used.
  • the solution 102 and the drug 105 manufactured by the pharmaceutical company are sealed in the drug storage chamber 103 and the drug 105 in the drug storage chamber 106 in the drug company or the drug enclosure factory, respectively ( It is cut off from outside air). Then, the drug container 101 is delivered to the hospital in a state where the dissolution liquid 102 and the drug 105 are sealed.
  • the drug container 101 In a hospital where the drug container 101 is delivered, first, when a medical worker (for example, a nurse) breaks the rupture film 113 immediately before instilling a patient, the drug 105 in the drug storage chamber 106 is removed.
  • the medicine 105 is supplied to the medicine storage chamber 103 through the medicine supply path 104, and the medicine 105 is dissolved in the solution 102 in the medicine storage chamber 103.
  • the rupture film 113 has a sufficiently thin film shape by the two planar bodies constituting the outer peripheral plane part 110, so that by applying a force from the outside to this part, a state of being easily separated can be obtained. It can be canceled.
  • FIG. 13 is a schematic diagram for explaining the operation of dissolving the drug in the solution using the stirring device.
  • FIG. 14 is an enlarged front view of a main part in FIG.
  • the drug agitating unit 109 is on the lower side,
  • the medicine container 101 is set in the stirring device 114 shown in FIG. Thereafter, the stirrer 108 housed in the drug stirring unit 9 in the drug container 101 is rotated by the stirring device 114 to dissolve the solution 102 and the drug 105.
  • the stirring device 114 in the present embodiment incorporates a drive unit 115.
  • a housing 117 having a recess 116 for placing the medicine stirring part 109 of the medicine container 101 is provided on the driving part 115.
  • a turbidity measuring unit 118 for measuring the turbidity of the drug stirring unit 109 of the drug container 101 is provided on the top of the casing 117.
  • the stirring device 114 includes a notification unit 119 for notifying the outside of the operation (for example, a medical worker, etc.) of the operation completion when the operation of dissolving the drug 105 and the solution 102 is completed, and the driving unit 115 and turbidity measurement.
  • the control unit 120 is connected to the notification unit 119 and controls the operation of the driving unit 115 and the notification unit 119.
  • the drive unit 115 has a mechanism for rotating a magnet connected to a motor. Therefore, when the motor of the drive unit 115 rotates, the stirrer 108 in the medicine container 101 can also be rotated so as to follow it.
  • the drug stirring unit 109 in which the stirring bar 108 in the drug container 101 is arranged is formed to be cylindrical (configured with a cylindrical container). Thereby, the stirring bar 108 can be rotated more smoothly in the drug stirring unit 109.
  • medical agent container 101 is formed with the transparent material (it is comprised with the transparent container). Thereby, the turbidity measuring unit 118 of the stirring device 114 can measure the turbidity of the solution 102 inside the drug stirring unit 109, that is, the degree of dissolution of the solution 102 and the drug 105.
  • FIG. 15 is a flowchart showing an operation of dissolving the drug in the solution using the stirring device 114 in the drug container storing the solution and the drug according to the present embodiment.
  • the drug stirring unit 109 of the drug container 101 is set in the recess 116 of the casing 117 of the stirring device 114 (S1 in FIG. 15). At this time, the suspension arm 122 is passed through the holding portion 112 to be held from above. Next, the type and amount of the solution 102 and the drug 105 stored in the drug container 101 are input to the control unit 120 of the stirring device 114 (S2 in FIG. 15).
  • a barcode on which information including the type and amount of the dissolved solution 102 and the medicine 105 stored in advance is read by a barcode reader (not shown) mounted on the stirring device 114. Then, the information read by the barcode reader is input to the control unit 120, whereby the types and amounts of the solution 102 and the drug 105 are input.
  • the first rotation speed N1 for rotating the stirrer 108 and the first rotation time (T1) for rotating the stirrer 108 are determined. To do.
  • the rotation operation of the drive unit 115 is started, and control is performed so that the rotation speed of the stirrer 108 becomes the first rotation speed (N1) (S3 in FIG. 15, first stirring operation).
  • the dissolution experiment of the dissolution liquid 102 and the drug 105 is performed in advance, and the rotation speed and rotation speed of the stirrer 108 for sufficiently dissolving the drug 105 in the dissolution liquid 102 are obtained. That is, the rotation speed and rotation time obtained in the dissolution experiment are respectively set as a first rotation speed N1 and a first rotation time (T1) in a memory (not shown) inside the control unit 120 of the stirring device 114. Stored in advance.
  • the first rotation speed N1 for rotating the stirrer 108 and the first rotation time (T1) for rotating the stirrer 108 ) And are set.
  • the time (T) from the start of the first stirring operation is measured, and the time (T) from the start of the first stirring operation is determined as the first rotation time ( It is determined whether or not T1) has elapsed (T> T1) (S4 in FIG. 15).
  • T the process proceeds to the next step.
  • T ⁇ T1 the first stirring operation in S3 in FIG. 15 is continued.
  • the control unit 120 of the stirring device 114 measures and determines the time (T) from the start of the first stirring operation.
  • T> T1 the rotational speed of the stirrer 108 is decreased (S5 in FIG. 15).
  • the rotation speed is half of the first rotation speed N1 (0.5 ⁇ N1).
  • this operation is performed by the control unit 120 of the stirring device 114.
  • the reason why the rotational speed of the stirrer 108 is decreased is that the vortex 121 (see FIG. 14) in the drug stirring unit 109 is reduced, and this vortex 121 affects the turbidity measurement in the next step. This is to prevent it from occurring.
  • the turbidity measuring unit 118 of the stirring device 114 measures the turbidity of the solution 102 inside the drug stirring unit 109 (FIG. S6 in 15).
  • a dissolution experiment of the dissolution liquid 102 and the drug 105 is performed in advance, the turbidity when the drug 105 is completely dissolved in the dissolution liquid 102 is measured, and the turbidity is controlled by the stirring device 114.
  • the desired turbidity is stored in a memory (not shown) inside the unit 120. Thereby, the stored desired turbidity and the actually measured turbidity are compared to determine whether or not the desired turbidity is equal to or higher than the desired turbidity.
  • the rotation of the stirrer 108 is stopped (S8 in FIG. 15).
  • the notifying unit 119 of the stirrer 114 notifies the outside of the stirrer 114 that the dissolution of the dissolving liquid 102 and the drug 105 has been completed (S9 in FIG. 15).
  • a form in which an indicator lamp is turned on is used as the notification unit 119.
  • the second rotation speed N2 for rotating the stirrer 108 and the second rotation for rotating the stirrer 108 are performed.
  • the time (T2) is determined, and the rotational operation of the drive unit 115 is started, and control is performed so that the rotational speed of the stirrer 108 becomes the second rotational speed (N2) (S10 in FIG. 2 stirring operation).
  • the second rotation speed N2 is set to the same rotation speed as the first rotation speed N1, and the second rotation time (T2) is set to 5 minutes. Yes.
  • the time (Ta) from the start of the second stirring operation is measured, and the time (Ta) from the start of the second stirring operation is inputted as the second rotation time (T2). Is determined (Ta> T2) (S11 in FIG. 15).
  • the process proceeds to S5 in FIG. 15 (reducing the rotational speed of the stirrer 108), and then the turbidity of the solution 102 inside the drug stirring unit 109 is measured. If Ta ⁇ T2, the second stirring operation is continued (see S11). That is, the second stirring operation is continued until the turbidity of the solution 102 inside the drug stirring unit 109 becomes equal to or higher than the desired turbidity.
  • a drug is used that becomes cloudy when the drug 105 is dissolved in the solution 102.
  • the turbidity measuring unit 118 may measure the transparency.
  • the drug 105 in the drug storage chamber 106 is supplied to the solution 102 in the drug storage chamber 103 via the drug supply path 104 and then provided in the drug stirring unit 109.
  • the drug 105 can be automatically dissolved in the dissolving liquid 102 by rotating the stirring bar 108. As a result, it is possible to provide a drug container with higher workability than before.
  • the drug 105 is, for example, a drug used for instillation treatment of cancer
  • the solution 102 is stored in the drug storage chamber 103 and the drug 105 is stored in the drug storage chamber 106 in a state of being shielded from the outside air, and only the rupture film 113 is broken during mixing. Both can be mixed. Therefore, it is possible to prevent the medical staff from being violated by the toxicity of the medicine.
  • FIG. 16 is a front view of the medicine container according to the present embodiment.
  • the medicine storage chambers 201, 202, and 203 are connected to the medicine supply paths 204, 204, and 204, respectively. Further, a single medicine supply port 205 is provided on the opposite side of each medicine supply path 204, 204, 204 from the medicine storage chambers 201, 202, 203. Further, an opening / closing valve 206 is provided at a portion of the medicine supply path 204 to which the medicine storage chambers 201, 202, and 203 are connected.
  • the on-off valve 206 has a handle 207 that switches the open / close state of the on-off valve 206.
  • the handle 207 can be rotated only in one counterclockwise direction within a range from a dotted line (1) to a dotted line (5) in FIG.
  • the handle 207 can be fixed at each position of the dotted line (1), the dotted line (2), the dotted line (3), the dotted line (4), and the dotted line (5).
  • the open / close state of the medicine storage chambers 201, 202, 203 and the medicine supply port 205 is changed as follows (1) to (5). It can be switched sequentially.
  • First drug storage chamber (that is, drug storage chamber 201) and drug supply port 205 are open (S102 in FIG. 18).
  • the medicine storage chambers 201, 202, and 203 are made of flexible cylindrical members.
  • the medicine storage chambers 201, 202, and 203 are each covered with a flexible and transparent cover 208 on the front and back surfaces.
  • a drug supply port 205 is provided on the outer side of the cover 208 on the first end side, and a hanging hole 209 for adjusting the drug is provided on the first end side of the cover 208.
  • a suspension hole 210 for drug administration is provided on the second end side of the cover 208 opposite to the first end.
  • the medicine container is oriented so that the medicine supply port 205 (that is, the hanging hole 209 at the time of medicine adjustment) comes to the top, and the medicine manufactured by the pharmaceutical company is used in the pharmaceutical company or the medicine enclosure factory. From the medicine supply port 205, the medicine is stored in the medicine storage chambers 201, 202, 203.
  • the drugs stored in the drug storage chambers 201, 202, and 203 are referred to as drugs 211, 212, and 213, respectively.
  • the drug supply port 205 is closed. Therefore, the medicines 211, 212, and 213 are sealed in the medicine storage chambers 201, 202, and 203, respectively.
  • the drug container is delivered to the hospital as a drug-containing drug container in this sealed state.
  • the handle 7 of the opening / closing valve 206 of the medicine container containing the medicine is not connected to any of the above-described dotted line (1) (the medicine storage chambers 201, 202, 203 are in the closed state). (See FIG. 17A)).
  • the medicine 219 and the medicine 212 are mixed in the medicine storage chamber 202 (see FIG. 17B).
  • the dosage of the medicine mixed in the medicine storage chamber 202 is adjusted using the suction member (see FIG. 17C).
  • the patient is infused as follows. As shown in FIG. 16, the drug container is suspended by inserting a hook (not shown) into the suspension hole 210 at the time of drug administration so that the suspension hole 210 side at the time of drug administration is at the top.
  • an infusion needle (not shown) is connected to the medicine supply port 205 via a tube (not shown), and in this state, the infusion needle is inserted into the patient.
  • the handle 207 of the on-off valve 206 is rotated counterclockwise to the position indicated by the dotted line (2) (the medicine storage chamber 201 and the medicine supply port 205 are in the open state).
  • the medicine 211 stored in the medicine storage chamber 201 is administered to the patient from the drip needle (see FIG. 17D).
  • the handle 207 of the on-off valve 206 is rotated counterclockwise to the position of the dotted line (3) described above (the medicine storage chamber 202 and the medicine supply port 205 are in the open state).
  • the medicine 212 stored in the medicine storage chamber 202 is administered to the patient from the drip needle (see FIG. 17 (e)).
  • the handle 7 of the on-off valve 206 is rotated counterclockwise so as to be located at the position indicated by the dotted line (4) (the medicine storage chamber 203 and the medicine supply port 205 are open).
  • the medicine 213 stored in the medicine storage chamber 203 is administered to the patient from the drip needle (see FIG. 17 (f)).
  • the handle 207 of the on-off valve 206 is turned over. After rotating clockwise, the drip needle is removed from the patient after being positioned at the position of the dotted line (5) described above (not connected to any of the medicine storage chambers 201, 202, 203 (closed state)). .
  • the drug 211 is a physiological saline
  • the drug 212 is an anticancer drug
  • the drug 213 is a physiological saline
  • the drug container is used for infusion of cancer treatment
  • the switching operation of the administration medicine can be performed only by the switching operation of the on-off valve 206 inside the medicine container.
  • handling is very simple and the safety
  • this invention is not limited to this.
  • the present invention may be applied.
  • the on-off valve can switch the open / close state between the respective drug storage chambers 201, 202, 203 and the drug supply port in the order of (1) to (5) below.
  • a medicine container which can administer many kinds of medicines to a patient can be provided.
  • (1) Closed state (2) First drug storage chamber and drug supply port open state (3) Second drug storage chamber and drug supply port open state (4) N (where N is 2 (Natural number)
  • N is 2 (Natural number)
  • the medicine storage chamber and the medicine supply port are in the open state (5) in the closed state.
  • an example of the medicine container in which three kinds of medicines are switched in five stages by the opening / closing valve 206 is disclosed.
  • the present invention is not limited to this.
  • the medicine 211 is a physiological saline
  • the medicine 212 is an anticancer agent
  • the medicine 213 is a physiological saline
  • the physiological saline communicates with the medicine supply port 205
  • a medical worker can perform a connection operation. Harmless even if exposed to saline. Therefore, the first and last order in which the on-off valve 205 is closed is omitted, and the three open / close states of each medicine storage chamber and medicine supply port are switched in the order of (1) to (3) below. It can also be simplified in order.
  • First drug storage chamber ie, drug storage chamber 201 and drug supply port 205 are open
  • Second drug storage chamber ie, drug storage chamber 202) and drug supply port 205 are open
  • the third medicine storage chamber that is, the medicine storage chamber 203) and the medicine supply port 205 are open.
  • the handle 7 of the on-off valve 206 is rotated only in a certain direction (in this embodiment, Counterclockwise).
  • the negative pressure can be maintained in the medicine adjustment chamber by continuing the suction for some time after the on-off valve is closed. For this reason, there is a safety merit that the medicine is difficult to leak out during storage of the container after medication or at the time of disposal.
  • the present invention it is possible to adjust the amount of drug required for each individual different depending on the patient's physique, age, etc., by opening the on-off valve and moving some drugs to the drug adjustment room, Since it has an effect that workability can be improved as compared with the conventional case, it is expected to be widely used as a medicine container and a medicine container containing a medicine.

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

This drug container is provided with a drug-housing chamber (1) having a drug supply port (2), and a drug adjustment chamber (4) connected to the drug-housing chamber (1) via a drug adjustment channel (3). A vacuum port (5) is connected to the drug adjustment chamber (4). The drug adjustment channel (3) is provided with an opening/closing valve (6). When adjusting the amount of a drug (11) remaining in the drug-housing chamber (1), the opening/closing valve (6) is opened, and the surplus of the drug (11) is moved to the drug adjustment chamber (4) by removing air from the vacuum port (5).

Description

薬剤容器、及び薬剤を封入した薬剤入り容器Drug container and drug-filled container containing the drug
 本発明は、薬剤容器および薬剤を封入した薬剤入り容器に関するものである。 The present invention relates to a medicine container and a medicine container containing the medicine.
 例えば、点滴治療に用いられる薬剤容器は、薬剤供給口から薬剤収納室内に薬剤を流入させて構成されている。
 そして、点滴治療時には、薬剤供給口にチューブを介して点滴針を連結し、この点滴針を患者に差し込むことで、薬剤収納室内の薬剤が患者に投与される(例えば、下記特許文献1参照)。
For example, a drug container used for infusion treatment is configured by flowing a drug from a drug supply port into a drug storage chamber.
At the time of infusion treatment, an infusion needle is connected to the medicine supply port via a tube, and the infusion needle is inserted into the patient, whereby the medicine in the medicine storage chamber is administered to the patient (for example, see Patent Document 1 below). .
特開2004-290217号公報JP 2004-290217 A
 ここで、薬剤収納室内に収納される薬剤量は、患者の体格や年齢等によって、適量に設定される必要がある。このため、病院では、薬剤室において、個人毎に必要とする薬剤を、例えば、個別の薬剤瓶から注射針で吸引し、それを個人毎の薬剤容器の薬剤収納室内に注入する作業が発生する。つまり、この時には、薬剤瓶の取り出し、注射針の吸引、注入、薬剤瓶の収納、注射針の廃棄など、多くの手間を要するため、作業性の低下を招いていた。 Here, the amount of medicine stored in the medicine storage room needs to be set to an appropriate amount depending on the physique and age of the patient. For this reason, in a drug room, for example, a drug required for each individual is aspirated by an injection needle from an individual drug bottle and injected into a drug storage chamber of a drug container for each individual. . That is, at this time, it takes a lot of work such as taking out the medicine bottle, sucking and injecting the injection needle, storing the medicine bottle, and discarding the injection needle.
 そこで、本発明は、作業性を向上させることが可能な薬剤容器および薬剤を封入した薬剤入り容器を提供することを目的とするものである。
 上記目的を達成するために、本薬剤容器は、薬剤収納室と、薬剤調整室と、薬剤調整路と、吸引口と、開閉弁と、を備えている。薬剤収納室は、薬剤供給口を有する。薬剤調整室は、薬剤収納室に貯留された薬剤の調整を行うとともに、定形性を有する。薬剤調整路は、薬剤収納室と薬剤調整室とを連結する。吸引口は、薬剤調整室に連結されている。開閉弁は、薬剤調整路に設けられている。
Then, an object of this invention is to provide the chemical | medical agent container which can improve workability | operativity, and the chemical | medical agent container which enclosed the chemical | medical agent.
In order to achieve the above object, the drug container includes a drug storage chamber, a drug adjustment chamber, a drug adjustment path, a suction port, and an on-off valve. The medicine storage chamber has a medicine supply port. The medicine adjustment room adjusts the medicine stored in the medicine storage room and has a fixed shape. The medicine adjustment path connects the medicine storage room and the medicine adjustment room. The suction port is connected to the medicine adjustment chamber. The on-off valve is provided in the medicine adjustment path.
 本薬剤容器は、薬剤調整室と、薬剤投与口と、薬剤攪拌部と、を備えている。薬剤調整室は、溶解液を収納する。薬剤収納室は、薬剤調整室に薬剤供給路を介して連結されると共に、薬剤を収納する。薬剤投与口は、薬剤調整室に連結されている。薬剤攪拌部は、薬剤調整室に連結されると共に、その内部に攪拌子を収納可能である。
 また、本薬剤容器の使用方法は、複数の薬剤収納室と、複数の薬剤収納室の各々に連結された複数の薬剤供給路と、複数の薬剤供給路に開閉弁を介して接続された薬剤供給口と、を備えた薬剤容器の使用方法であって、開閉弁は、以下(1)~(5)の順番にて、それぞれの薬剤収納室と薬剤供給口との開閉状態を切り替える。
(1)閉状態
(2)1番目の薬剤収納室と前記薬剤供給口が開状態
(3)2番目の薬剤収納室と前記薬剤供給口が開状態
(4)N(ここで、Nは2以上の自然数)番目の薬剤収納室と前記薬剤供給口が開状態
(5)閉状態
The drug container includes a drug adjustment chamber, a drug administration port, and a drug stirring unit. The drug adjustment chamber stores the solution. The medicine storage chamber is connected to the medicine adjustment chamber via a medicine supply path and stores the medicine. The drug administration port is connected to the drug adjustment room. The drug stirring unit is connected to the drug adjusting chamber and can store a stirring bar therein.
The method of using the drug container includes a plurality of drug storage chambers, a plurality of drug supply passages connected to each of the plurality of drug storage chambers, and a drug connected to the plurality of drug supply paths via open / close valves. The on-off valve switches the open / close state of each medicine storage chamber and medicine supply port in the order of (1) to (5) below.
(1) Closed state (2) First drug storage chamber and drug supply port open state (3) Second drug storage chamber and drug supply port open state (4) N (where N is 2 (Natural number above) The drug storage chamber and the drug supply port are open (5) closed
 本発明の薬剤容器によれば、患者の体格や年齢等によって異なる個人毎に必要とする薬剤量の調整を、開閉弁を開放することで一部の薬剤を薬剤調整室に移動させることで行うことができるため、従来よりも作業性を向上させることができる。 According to the drug container of the present invention, adjustment of the drug amount required for each individual, which differs depending on the patient's physique and age, is performed by moving some drugs to the drug adjustment room by opening the on-off valve. Therefore, workability can be improved as compared with the conventional case.
本発明の実施の形態1に係る薬剤入り容器を示す正面図。The front view which shows the container with a chemical | medical agent which concerns on Embodiment 1 of this invention. 図1の薬剤入り容器の使用例を示す正面図。The front view which shows the usage example of the container containing a chemical | medical agent of FIG. 図1の薬剤入り容器の使用例を示す正面図。The front view which shows the usage example of the container containing a chemical | medical agent of FIG. 本発明の実施の形態2に係る薬剤入り容器を示す正面図。The front view which shows the container with a chemical | medical agent which concerns on Embodiment 2 of this invention. 本発明の実施の形態3に係る薬剤入り容器を示す正面図。The front view which shows the container with a chemical | medical agent which concerns on Embodiment 3 of this invention. 本発明の実施の形態4に係る薬剤入り容器を示す正面図。The front view which shows the container with a chemical | medical agent which concerns on Embodiment 4 of this invention. 本発明の実施の形態5に係る薬剤入り容器を示す正面図。The front view which shows the container with a chemical | medical agent which concerns on Embodiment 5 of this invention. 本発明の実施の形態6に係る薬剤入り容器を示す正面図。The front view which shows the container containing the chemical | medical agent which concerns on Embodiment 6 of this invention. 本発明の実施の形態7に係る薬剤入り容器を示す正面図。The front view which shows the container with a chemical | medical agent concerning Embodiment 7 of this invention. 本発明の実施の形態8に係る薬剤入り容器を示す正面図。The front view which shows the container with a chemical | medical agent which concerns on Embodiment 8 of this invention. 本発明の実施の形態9に係る薬剤容器を示す斜視図。The perspective view which shows the chemical | medical agent container which concerns on Embodiment 9 of this invention. 図11の薬剤容器の正面図。The front view of the chemical | medical agent container of FIG. 図11の薬剤容器を攪拌装置を用いて薬剤を溶解液に溶解させる動作を説明する概略図。Schematic explaining the operation | movement which melt | dissolves a chemical | medical agent in a solution using the stirring apparatus for the chemical | medical agent container of FIG. 図13中の要部拡大正面図。The principal part enlarged front view in FIG. 図11の薬剤容器を、攪拌装置を用いて薬剤を溶解液に溶解させる動作を示すフローチャート。The flowchart which shows the operation | movement which melt | dissolves a chemical | medical agent in a solution using the stirring apparatus for the chemical | medical agent container of FIG. 本発明の実施の形態10に係る薬剤入り容器を示す正面図。The front view which shows the container with a chemical | medical agent which concerns on Embodiment 10 of this invention. (a)~(f)は、図16の薬剤入り容器の使用手順を示す図。(A)-(f) is a figure which shows the use procedure of the container containing a chemical | medical agent of FIG. 図16の薬剤入り容器の使用方法を示すフローチャート。The flowchart which shows the usage method of the container with a chemical | medical agent of FIG.
 以下、本発明の一実施形態について、図面を用いて詳細に説明する。
 (実施の形態1)
 図1において、透明の薬剤収納室1は、薬剤供給口2を有している。また、薬剤収納室1には、薬剤調整路3を介して、透明の薬剤調整室4が連結されている。また、薬剤調整室4には、吸引口5が連結されている。さらに、薬剤調整路3には、開閉弁6が設けられている。
Hereinafter, an embodiment of the present invention will be described in detail with reference to the drawings.
(Embodiment 1)
In FIG. 1, a transparent medicine storage chamber 1 has a medicine supply port 2. A transparent medicine adjustment chamber 4 is connected to the medicine storage chamber 1 via a medicine adjustment path 3. A suction port 5 is connected to the medicine adjustment chamber 4. In addition, an on-off valve 6 is provided in the medicine adjustment path 3.
 薬剤収納室1は、円筒形状であって、可撓性を有している。これに対し、薬剤調整室4は、円筒形状であって定形性を有している。薬剤調整室4には、調整目盛り7が設けられている。
 本実施形態では、薬剤収納室1および薬剤調整室4のそれぞれの表裏面が、可撓性を有する透明のカバー8によって覆われている。そして、カバー8の第1端側における外部に、薬剤供給口2が設けられている。カバー8の第1端側には、薬剤調整時吊り下げ孔9が設けられている。また、カバー8における第1端とは反対側の第2端側には、薬剤投与時吊り下げ孔10が設けられている。さらに、カバー8の側辺部分には、吸引口5がカバー8外に向けて設けられている。
The medicine storage chamber 1 has a cylindrical shape and is flexible. On the other hand, the medicine adjustment chamber 4 is cylindrical and has a fixed shape. The medicine adjustment chamber 4 is provided with an adjustment scale 7.
In the present embodiment, the front and back surfaces of the medicine storage chamber 1 and the medicine adjustment chamber 4 are covered with a transparent cover 8 having flexibility. A medicine supply port 2 is provided outside the cover 8 on the first end side. On the first end side of the cover 8, a hanging hole 9 for adjusting the medicine is provided. In addition, a hanging hole 10 at the time of drug administration is provided on the second end side of the cover 8 opposite to the first end. Further, a suction port 5 is provided on the side portion of the cover 8 so as to face the outside of the cover 8.
 本実施形態においては、製薬会社で製造された薬剤が、製薬会社または薬剤封入工場において、図2に示すように、薬剤供給口2が上部に来る向きとし、薬剤供給口2から薬剤収納室1内に収納されている。この時、開閉弁6は、図1に示すように、閉状態となっている。また、薬剤11が薬剤収納室1内に供給された後には、薬剤供給口2も閉状態となっている。このため、薬剤11が薬剤収納室1内に封入された状態となっており、この封入状態のまま薬剤入り薬剤容器として病院に納品される。 In the present embodiment, the medicine manufactured by the pharmaceutical company is in the direction of the medicine supply port 2 facing upward, as shown in FIG. It is stored inside. At this time, the on-off valve 6 is closed as shown in FIG. In addition, after the medicine 11 is supplied into the medicine storage chamber 1, the medicine supply port 2 is also closed. For this reason, the medicine 11 is enclosed in the medicine storage chamber 1, and is delivered to the hospital as a medicine-containing medicine container in this enclosed state.
 薬剤11が納品された病院では、患者に対し、以下のようにして、薬剤11の点滴を行う。
 まず、図2に示すように、例えば、病室において、薬剤調整時吊り下げ孔9側が上部に来る向きとした薬剤入り薬剤容器を、薬剤調整時吊り下げ孔9の部分をフック12によって吊り下げる。
In the hospital where the drug 11 is delivered, the drug 11 is infused to the patient as follows.
First, as shown in FIG. 2, for example, in a hospital room, a drug-containing drug container with the suspension hole 9 side at the time of drug adjustment facing upward is hung by the hook 12 at the portion of the suspension hole 9 at the time of drug adjustment.
 次に、注射器13、または吸引器14が、吸引口5に挿入される。
 その後、図2に示すように、開閉弁6を開状態とする。
 次に、注射器13、または吸引器14によって、薬剤調整室4内の空気が吸引される。すると、薬剤収納室1内の薬剤11が、薬剤調整路3を介して薬剤調整室4内に移動する。
Next, the syringe 13 or the suction device 14 is inserted into the suction port 5.
Thereafter, as shown in FIG. 2, the on-off valve 6 is opened.
Next, the air in the medicine adjustment chamber 4 is aspirated by the syringe 13 or the aspirator 14. Then, the medicine 11 in the medicine storage chamber 1 moves into the medicine adjustment chamber 4 via the medicine adjustment path 3.
 これにより、薬剤調整室4への薬剤11の移動量によって、薬剤収納室1内に残存する薬剤11の量が設定される。
 つまり、患者の体格や年齢等に応じた適切な量の点滴が行えるように、薬剤収納室1内に残存する薬剤11の量が設定される。
 この時、予め薬剤収納室1内に、例えば、1000ccの薬剤11が充填されている状態で、上述したように、薬剤調整室4内に150cc移動させると、薬剤収納室1内には、850ccの薬剤11が貯留される。
Thereby, the amount of the medicine 11 remaining in the medicine storage chamber 1 is set according to the amount of movement of the medicine 11 to the medicine adjustment chamber 4.
That is, the amount of the drug 11 remaining in the drug storage chamber 1 is set so that an appropriate amount of infusion can be performed according to the patient's physique and age.
At this time, if the drug storage chamber 1 is filled with, for example, 1000 cc of the drug 11 and 150 cc is moved into the drug adjustment chamber 4 as described above, the drug storage chamber 1 has 850 cc. The drug 11 is stored.
 そして、例えば、薬剤収納室1内に850ccの薬剤11を準備した後、まず、開閉弁6を閉状態とし、次に、吸引口5から上述した注射器13、または吸引器14を引き抜く。
 このとき、吸引口5から、注射器13または吸引器14を引き抜くと、吸引口5は自動的に閉状態となる。
For example, after preparing 850 cc of medicine 11 in the medicine storage chamber 1, first, the on-off valve 6 is closed, and then the above-described syringe 13 or suction device 14 is pulled out from the suction port 5.
At this time, when the syringe 13 or the suction device 14 is pulled out from the suction port 5, the suction port 5 is automatically closed.
 その後、図3に示すように、薬剤投与時吊り下げ孔10側が上方になるようにして、フック12に薬剤投与時吊り下げ孔10を吊り下げる。
 次に、薬剤供給口2にチューブ15を介して、点滴針16を連結し、この状態で、点滴針16を患者に差し込む。なお、薬剤供給口2にチューブ15が連結されると、薬剤供給口2は、開放状態となっている。従って、この状態で、チューブ15に介在させた開閉弁(図示せず)を開放すれば、薬剤収納室1内の薬剤11が、点滴針16から患者に投与される。
Thereafter, as shown in FIG. 3, the suspension hole 10 at the time of drug administration is suspended from the hook 12 so that the suspension hole 10 side at the time of drug administration faces upward.
Next, the infusion needle 16 is connected to the medicine supply port 2 via the tube 15, and in this state, the infusion needle 16 is inserted into the patient. When the tube 15 is connected to the medicine supply port 2, the medicine supply port 2 is in an open state. Therefore, in this state, if the on-off valve (not shown) interposed in the tube 15 is opened, the medicine 11 in the medicine storage chamber 1 is administered to the patient from the drip needle 16.
 以上の説明で明らかなように、本実施形態の薬剤容器では、患者の体格や年齢等に応じて異なる個人毎に必要とされる薬剤11の量の調整は、開閉弁6を開放することで一部の薬剤11を薬剤調整室4に移動させることで行うことができる。よって、従来よりも作業性を向上させることができる。
 また、以上の説明からも明らかなように、調整した薬剤11は、薬剤調整室4に移動させられるだけで、本実施形態の薬剤容器外に取り出されることはない。よって、この点からも、取り扱いが容易で、作業性の高い薬剤容器を提供することができる。
As is clear from the above description, in the drug container of the present embodiment, the amount of the drug 11 required for different individuals depending on the patient's physique and age is adjusted by opening the on-off valve 6. This can be done by moving some drugs 11 to the drug adjustment chamber 4. Therefore, workability can be improved as compared with the prior art.
Further, as apparent from the above description, the adjusted medicine 11 is merely moved to the medicine adjustment chamber 4 and is not taken out of the medicine container of the present embodiment. Therefore, also from this point, it is possible to provide a drug container that is easy to handle and has high workability.
 例えば、薬剤11が、がん治療薬であった場合には、作業者の安全上、薬剤11に触れることすら避ければならない場合がある。
 本実施形態の薬剤容器では、調整済みの薬剤11は、薬剤調整室4に移動させるだけで、薬剤容器外に取り出されないため、その取り扱いが極めて簡便で、作業性の高いものとすることができる。
For example, when the drug 11 is a cancer drug, it may be necessary to avoid even touching the drug 11 for the safety of the operator.
In the medicine container of this embodiment, the adjusted medicine 11 is simply moved to the medicine adjustment chamber 4 and is not taken out of the medicine container, so that the handling thereof is extremely simple and has high workability. it can.
 (実施の形態2)
 図4は、本発明の実施の形態2に係る薬剤入り容器の構成を示している。
 薬剤収納室1には、第1の連通部として設けた破断膜17を介して副薬剤収納室18が連結されている。
 つまり、副薬剤収納室18には、他の薬剤19が収納されている。
(Embodiment 2)
FIG. 4 shows the configuration of a medicine container according to Embodiment 2 of the present invention.
A sub-drug storage chamber 18 is connected to the drug storage chamber 1 via a rupture film 17 provided as a first communication portion.
That is, another medicine 19 is stored in the auxiliary medicine storage chamber 18.
 本薬剤容器は、点滴直前に、まず、破断膜17が破断され、薬剤19と薬剤11とが混合される。
 次に、上述したように、患者の体格や年齢等を考慮して、混合状態の薬剤11,19の量を調整し(一部を薬剤調整室4に移動)、その状態で点滴を行う。
 (実施の形態3)
 図5は、本発明の実施の形態3に係る薬剤入り容器の構成を示している。
In the drug container, immediately before the drip, the rupture film 17 is first broken, and the drug 19 and the drug 11 are mixed.
Next, as described above, in consideration of the patient's physique, age, etc., the amounts of the drugs 11 and 19 in the mixed state are adjusted (partially moved to the drug adjustment chamber 4), and infusion is performed in that state.
(Embodiment 3)
FIG. 5 shows the structure of the medicine container according to Embodiment 3 of the present invention.
 本実施形態の薬剤容器では、薬剤収納室1内に粉末状の薬剤20が収納されている。
 また、薬剤収納室1には、第1の連通部として破断膜21が設けられている。
 破断膜21介して連結された副薬剤収納室22には、液状の薬剤23が収納されている。
 さらに、薬剤収納室1には、第1の連通部として副開閉弁24が設けられている。
In the drug container of this embodiment, a powdered drug 20 is stored in the drug storage chamber 1.
Further, the medicine storage chamber 1 is provided with a rupture film 21 as a first communication portion.
A liquid medicine 23 is stored in the secondary medicine storage chamber 22 connected via the rupture film 21.
Further, the medicine storage chamber 1 is provided with a sub open / close valve 24 as a first communication portion.
 副開閉弁24を介して連結された副薬剤収納室25には、液状の薬剤26が収納されている。
 このため、点滴直前には、まず、破断膜21を破断して薬剤23と薬剤20とを混合させると共に、副開閉弁24を開放して、薬剤26を薬剤収納室1内に流入させて混合させる。
A liquid medicine 26 is housed in the secondary medicine storage chamber 25 connected via the secondary opening / closing valve 24.
For this reason, immediately before the drip, first, the rupture film 21 is broken to mix the drug 23 and the drug 20, and the sub-open / close valve 24 is opened to allow the drug 26 to flow into the drug storage chamber 1 and mix. Let
 そして、上述したように、患者の体格や年齢等を考慮して、混合状態の薬剤20,23,26の量を調整し(一部を薬剤調整室4に移動)、その状態で、点滴を行う。
 (実施の形態4)
 図6は、本発明の実施の形態4に係る薬剤入り容器の構成を示している。
 本実施形態では、吸引口5には、吸引部材27が連結されている。
Then, as described above, taking into account the patient's physique and age, etc., the amount of the drug 20, 23, 26 in the mixed state is adjusted (partially moved to the drug adjustment room 4), and in this state, the infusion is performed. Do.
(Embodiment 4)
FIG. 6 shows the configuration of a medicine container according to Embodiment 4 of the present invention.
In the present embodiment, a suction member 27 is connected to the suction port 5.
 つまり、上述した実施の形態1~3の薬剤容器では、吸引口5に、注射器13、または吸引器14を連結する必要があったが、本実施の形態では、吸引口5に、吸引部材27を連結することで、薬剤収納室1内の薬剤(例えば、薬剤11)を薬剤調整室4に、より簡単に移動させることができる。
 (実施の形態5)
 図7は、本発明の実施の形態5に係る薬剤入り容器の構成を示している。
That is, in the drug containers of Embodiments 1 to 3 described above, it is necessary to connect the syringe 13 or the suction device 14 to the suction port 5, but in this embodiment, the suction member 27 is connected to the suction port 5. By connecting these, the medicine (for example, medicine 11) in medicine storage room 1 can be moved to medicine adjustment room 4 more easily.
(Embodiment 5)
FIG. 7 shows the structure of a medicine container according to Embodiment 5 of the present invention.
 本実施形態では、薬剤調整室4に第2の連通部として設けられた破断膜28を介して連結された副薬剤収納室29が設けられている。
 本実施形態では、副薬剤収納室29には、薬剤収納室1に収納された薬剤11を中和する中和剤、もしくは薬剤収納室1に収納された薬剤11を無毒化する失効剤として薬剤30が収納されている。
In the present embodiment, a secondary drug storage chamber 29 connected to the drug adjustment chamber 4 via a rupture film 28 provided as a second communication portion is provided.
In the present embodiment, the secondary drug storage chamber 29 has a drug as a neutralizing agent that neutralizes the drug 11 stored in the drug storage chamber 1 or a deactivating agent that detoxifies the drug 11 stored in the drug storage chamber 1. 30 is stored.
 つまり、上記実施の形態1~4においては、薬剤収納室1内の薬剤(例えば、薬剤11)を薬剤調整室4に移動させた後、何も処理を行わない。
 一方、本実施の形態のように、薬剤調整室4に、第2の連通部として設けられた破断膜28を介して連結された副薬剤収納室29を設けることによって、薬剤収納室1内の薬剤(例えば、薬剤11)を薬剤調整室4に移動させた後、薬剤(例えば、薬剤11)と、副薬剤収納室29に収納された薬剤30とを混合させる処理を容易に実施することができる。
That is, in the first to fourth embodiments, after the medicine (for example, medicine 11) in the medicine storage chamber 1 is moved to the medicine adjustment chamber 4, no processing is performed.
On the other hand, as in the present embodiment, by providing a secondary drug storage chamber 29 connected to the drug adjustment chamber 4 via a rupture film 28 provided as a second communication portion, the inside of the drug storage chamber 1 is provided. After moving the medicine (for example, medicine 11) to the medicine adjustment chamber 4, it is possible to easily perform a process of mixing the medicine (for example, medicine 11) and the medicine 30 stored in the auxiliary medicine storage chamber 29. it can.
 例えば、副薬剤収納室29に収納された薬剤30を、薬剤収納室1に収納された薬剤(例えば、薬剤11)を中和する中和剤、もしくは薬剤収納室1に収納された薬剤を無毒化する失効剤等を用いた場合は、薬剤収納室1に収納された薬剤(例えば、薬剤11)を中和したり無毒化したりすることができる。
 特に、薬剤(例えば、薬剤11)が、がん治療薬であった場合には、非常に毒性が高いため、薬剤収納室1に収納された薬剤(例えば、薬剤11)を薬剤調整室4に移動させた後、中和したり無毒化したりすることができるという点で、極めて有用である。
For example, the medicine 30 stored in the auxiliary medicine storage chamber 29 is neutralized with the neutralizing agent that neutralizes the medicine stored in the medicine storage chamber 1 (for example, the medicine 11) or the medicine stored in the medicine storage chamber 1. When a reversible agent or the like is used, a medicine (for example, medicine 11) stored in the medicine storage chamber 1 can be neutralized or detoxified.
In particular, when the drug (for example, drug 11) is a cancer therapeutic drug, it is very toxic, so the drug (for example, drug 11) stored in the drug storage chamber 1 is stored in the drug adjustment chamber 4. It is extremely useful in that it can be neutralized or detoxified after being transferred.
 (実施の形態6)
 図8は、本発明の実施の形態6に係る薬剤入り容器の構成を示している。
 本実施形態では、薬剤調整室4と吸引口5間に、気液分離膜31が設けられている。
 上述した実施の形態1~5においては、まず、注射器13(図2参照)、または吸引器14(図2参照)が吸引口5に挿入される。
(Embodiment 6)
FIG. 8 shows the configuration of a medicine container according to Embodiment 6 of the present invention.
In the present embodiment, a gas-liquid separation membrane 31 is provided between the drug adjustment chamber 4 and the suction port 5.
In the first to fifth embodiments described above, first, the syringe 13 (see FIG. 2) or the suction device 14 (see FIG. 2) is inserted into the suction port 5.
 その後、開閉弁6を開状態とする。
 次に、注射器13、または吸引器14によって、薬剤調整室4内の空気を吸引すると、薬剤収納室1内の薬剤(例えば、薬剤11)が、薬剤調整路3を介して薬剤調整室4内に移動する。
 ここで、薬剤収納室1内の薬剤(例えば、薬剤11)が、薬剤調整路3を介して薬剤調整室4内に移動する際には、薬剤(例えば、薬剤11)の種類によっては、微量の薬剤が吸引による陰圧によって霧状化してしまうおそれがある。そのような薬剤を用いた場合、その霧状化した微量の薬剤が吸引口5から外部へ漏れ出してしまうおそれがある。その結果、この薬剤容器を用いて点滴等を行う医療従事者(例えば、看護師)自身に触れてしまうおそれがある。
Thereafter, the on-off valve 6 is opened.
Next, when the air in the drug adjustment chamber 4 is sucked by the syringe 13 or the suction device 14, the drug (for example, the drug 11) in the drug storage chamber 1 passes through the drug adjustment path 3 in the drug adjustment chamber 4. Move to.
Here, when the medicine (for example, medicine 11) in the medicine storage chamber 1 moves into the medicine adjustment room 4 via the medicine adjustment path 3, a small amount of the medicine (for example, medicine 11) depends on the type. There is a risk that the drug will be atomized by negative pressure due to suction. When such a chemical | medical agent is used, there exists a possibility that the atomized trace amount chemical | medical agent may leak outside from the suction opening 5. FIG. As a result, there is a risk of touching a medical worker (for example, a nurse) who performs infusion or the like using this medicine container.
 つまり、上記実施の形態1~5においては、薬剤(例えば、薬剤11)が毒性のある薬剤(例えば、がんの点滴治療に用いられるような薬剤)である場合、薬剤調整室4内の空気を吸引する作業を行う際に、その霧状化した微量の薬剤が吸引口5から外部へ漏れ出してしまうおそれがあった。その結果、この薬剤容器を用いて点滴等を行う医療従事者自身が薬剤の毒性に犯されてしてしまうおそれがあった。 In other words, in the first to fifth embodiments, when the drug (for example, drug 11) is a toxic drug (for example, a drug used for instillation treatment of cancer), the air in the drug adjustment chamber 4 When performing the operation | work which attracts | sucks, there existed a possibility that the atomized trace amount chemical | medical agent might leak out from the suction opening 5 outside. As a result, there is a risk that the medical staff who performs intravenous infusion using this drug container may be violated by the toxicity of the drug.
 しかしながら、本実施形態においては、薬剤調整室4と吸引口5との間に、気液分離膜31が設けられている。このため、その霧状化した微量の薬剤(例えば、薬剤11)を、気液分離膜31によって吸収することができる。その結果、霧状化した微量の薬剤(例えば、薬剤11)の外部への漏れ出しを防止することができる。よって、この薬剤容器を用いて点滴等を行う医療従事者自身が毒性に犯されてしまうことを防止することができる。 However, in this embodiment, a gas-liquid separation membrane 31 is provided between the drug adjustment chamber 4 and the suction port 5. For this reason, the atomized trace amount medicine (for example, medicine 11) can be absorbed by gas-liquid separation membrane 31. As a result, it is possible to prevent leakage of the atomized small amount of medicine (for example, medicine 11) to the outside. Therefore, it is possible to prevent the medical staff who performs intravenous infusion using this drug container from being violated by toxicity.
 (実施の形態7)
 図9は、本発明の実施の形態9に係る薬剤入り容器の構成を示している。
 本実施形態では、薬剤調整室4に、第1の薬剤収納室1に収納された薬剤(例えば、薬剤11)の量を示すための薬剤投与目盛り32が設けられている。
 つまり、上記実施の形態1~6においては、図1~図8に示すように、調整目盛り7は、開閉弁6側から吸引口5側に向けて、順次数字が大きくなるように記述されている。
(Embodiment 7)
FIG. 9 shows the configuration of a medicine container according to Embodiment 9 of the present invention.
In the present embodiment, the medicine adjustment chamber 4 is provided with a medicine administration scale 32 for indicating the amount of medicine (for example, medicine 11) stored in the first medicine storage chamber 1.
In other words, in the first to sixth embodiments, as shown in FIGS. 1 to 8, the adjustment scale 7 is described so that the numbers increase sequentially from the opening / closing valve 6 side to the suction port 5 side. Yes.
 これに対して、本実施形態の薬剤入り容器は、薬剤投与目盛り32が、開閉弁6側から吸引口5側に向けて、順次数字が小さくなるように記述されている。
 言い換えると、上述した実施の形態1~6においては、上記実施の形態1にて説明したように、調整目盛り7は、薬剤(例えば、薬剤11)の薬剤収納室1から薬剤調整室4内へ移動量を示すものである。
On the other hand, the medicine container of the present embodiment is described such that the medicine administration scale 32 has a numerical value that decreases sequentially from the opening / closing valve 6 side to the suction port 5 side.
In other words, in the above-described first to sixth embodiments, as described in the first embodiment, the adjustment scale 7 is moved from the medicine storage chamber 1 of the medicine (for example, medicine 11) into the medicine adjustment chamber 4. It shows the amount of movement.
 一方、本実施形態では、薬剤投与目盛り32は、薬剤(例えば、薬剤11)の薬剤収納室1から薬剤調整室4内への移動後における、薬剤収納室1に収納された薬剤(例えば、薬剤11)の量を示すために設けられている。
 以下に、本実施形態に係る具体例を説明する。
 例えば、本薬剤容器では、予め薬剤収納室1内に、400ccの薬剤(例えば、薬剤11)が充填されている。
On the other hand, in the present embodiment, the medicine administration scale 32 is a medicine (for example, medicine) stored in the medicine storage chamber 1 after the medicine (for example, medicine 11) is moved from the medicine storage room 1 into the medicine adjustment room 4. 11) is provided to show the quantity.
Below, the specific example which concerns on this embodiment is demonstrated.
For example, in this medicine container, 400 cc medicine (for example, medicine 11) is filled in the medicine storage chamber 1 in advance.
 次に、薬剤調整室4の薬剤投与目盛り32の250ccの位置(図9中の点線A)まで、薬剤(例えば、薬剤11)を、薬剤収納室1から薬剤調整室4内へ移動させる。この結果、薬剤収納室1内には、薬剤調整室4の薬剤投与目盛り32に示す量と同等の250ccの薬剤(例えば、薬剤11)が準備される(薬剤調整室4内には、実際には150ccが移動された状態。)。 Next, the medicine (for example, medicine 11) is moved from the medicine storage chamber 1 into the medicine adjustment chamber 4 to the position of 250 cc (dotted line A in FIG. 9) of the medicine administration scale 32 in the medicine adjustment chamber 4. As a result, 250 cc of medicine (for example, medicine 11) equivalent to the amount shown in the medicine administration scale 32 of the medicine adjustment room 4 is prepared in the medicine storage room 1 (in the medicine adjustment room 4, actually Is the state where 150cc has been moved.)
 以上のように、本実施形態においては、薬剤収納室1から薬剤調整室4内への移動後における薬剤収納室1内の薬剤(例えば、薬剤11)の量を、医療従事者(例えば、看護師)自身が計算する必要はない。つまり、医療従事者は、薬剤投与目盛り32を直接読み取ることによって、薬剤収納室1内の薬剤(例えば、薬剤11)の量を、患者個人毎に必要とされる量になるように、より容易に調整することができる。 As described above, in this embodiment, the amount of the medicine (for example, medicine 11) in the medicine storage room 1 after the movement from the medicine storage room 1 into the medicine adjustment room 4 is determined by the medical worker (for example, nursing) Master) You don't have to do it yourself. That is, the medical staff can more easily adjust the amount of the medicine (for example, the medicine 11) in the medicine storage chamber 1 to the amount required for each patient by directly reading the medicine administration scale 32. Can be adjusted.
 さらに、薬剤収納室1内の薬剤(例えば、薬剤11)の量を、医療従事者(例えば、看護師)自身が計算する必要がないため、その結果として、計算ミス等による医療事故の発生リスクをより効果的に低減することができる。
 (実施の形態8)
 図10は、本発明の実施の形態8に係る薬剤入り容器の構成を示している。
Furthermore, since it is not necessary for the medical staff (for example, nurse) to calculate the amount of the medicine (for example, the medicine 11) in the medicine storage chamber 1, the risk of occurrence of a medical accident due to a calculation error or the like as a result. Can be more effectively reduced.
(Embodiment 8)
FIG. 10 shows a configuration of a medicine container according to Embodiment 8 of the present invention.
 本実施形態では、薬剤投与目盛り32が付された薬剤調整室4内が、真空になっている点で、上記実施の形態7の構成とは異なっている。
 すなわち、本実施形態の薬剤入り容器では、薬剤調整室4内に薬剤11の一部を吸引するために、薬剤調整室4内を真空状態としている。
 これにより、図6に示す吸引部材27や、図9に示す吸引口5が設けられていない構成であっても、開閉弁6を操作することで、容易に薬剤調整室4内へ適量の薬剤11を移動させることができる。
The present embodiment is different from the configuration of the seventh embodiment in that the inside of the medicine adjustment chamber 4 with the medicine administration scale 32 is evacuated.
That is, in the medicine container of the present embodiment, the inside of the medicine adjustment chamber 4 is in a vacuum state in order to suck a part of the medicine 11 into the medicine adjustment chamber 4.
Accordingly, even if the suction member 27 shown in FIG. 6 or the suction port 5 shown in FIG. 9 is not provided, an appropriate amount of medicine can be easily introduced into the medicine adjustment chamber 4 by operating the on-off valve 6. 11 can be moved.
 (実施の形態9)
 まず、本実施形態における薬剤容器の構成に関して説明する。
 図11は、本実施の形態に係る薬剤容器を示す斜視図である。また、図12は、本実施の形態に係る薬剤容器を示す正面図である。
 本実施形態の薬剤容器101は、図11、図12に示すように、溶解液102を収納する円筒形状の薬剤収納室103と、薬剤収納室103に筒状の薬剤供給路104を介して連結されると共に薬剤105を収納した偏平袋状の薬剤収納室106と、円筒形状の薬剤収納室103の第1端側に連結された薬剤供給口107と、を備えている。
(Embodiment 9)
First, the structure of the medicine container in the present embodiment will be described.
FIG. 11 is a perspective view showing a medicine container according to the present embodiment. FIG. 12 is a front view showing the medicine container according to the present embodiment.
As shown in FIGS. 11 and 12, the drug container 101 of the present embodiment is connected to a cylindrical drug storage chamber 103 for storing a solution 102 and a drug storage chamber 103 via a cylindrical drug supply path 104. In addition, a flat bag-shaped drug storage chamber 106 storing the drug 105 and a drug supply port 107 connected to the first end side of the cylindrical drug storage chamber 103 are provided.
 ここで、本実施形態において、薬剤収納室106は、偏平袋状となっており、さらに外部から押圧されることで、自由に変形する可撓性を有している。一方、薬剤収納室103は定形性を有する円筒状に形成されているが、可撓性を有する円筒状の部材として形成してもよい。
 また、本実施形態では、円筒状の薬剤収納室103における第1端とは反対側の第2端側(薬剤供給口107とは反対側)には、その内部に攪拌子108が収納できる薬剤攪拌部109が連結されている。
Here, in this embodiment, the medicine storage chamber 106 has a flat bag shape, and has flexibility to be freely deformed by being pressed from the outside. On the other hand, although the medicine storage chamber 103 is formed in a cylindrical shape having a fixed shape, it may be formed as a cylindrical member having flexibility.
In the present embodiment, the medicine in which the stirrer 108 can be stored in the second end side (the side opposite to the drug supply port 107) opposite to the first end in the cylindrical drug storage chamber 103. The stirring unit 109 is connected.
 ここで、本実施形態において、薬剤攪拌部109は、透明かつ円筒状であって定形性を有しており、薬剤収納室103側が開口している。
 また、図11、図12に示すように、本実施形態における薬剤容器101は、薬剤収納室103の外周部分に、外周平面部110が設けられている。外周平面部110には、薬剤収納室106が設けられている。
Here, in this embodiment, the medicine stirring part 109 is transparent and cylindrical, has a regular shape, and the medicine storage chamber 103 side is open.
As shown in FIGS. 11 and 12, the drug container 101 according to the present embodiment is provided with an outer peripheral plane part 110 in the outer peripheral part of the drug storage chamber 103. The outer peripheral plane part 110 is provided with a medicine storage chamber 106.
 すなわち、外周平面部110は、二枚の平面体を貼り合わせて形成されている。これにより、薬剤収納室106を覆うとともに、この二枚の平面体の一部を貼付しない(非接着とする)ことで、上述した筒状の薬剤供給路104が形成される。
 薬剤供給路104には、薬剤収納室106と薬剤収納室103とを分離する破断膜113が設けられている。
That is, the outer peripheral flat part 110 is formed by bonding two flat bodies. Accordingly, the above-described cylindrical medicine supply path 104 is formed by covering the medicine storage chamber 106 and not sticking (non-adhering) a part of the two flat bodies.
The drug supply path 104 is provided with a rupture film 113 that separates the drug storage chamber 106 and the drug storage chamber 103.
 外周平面部110における薬剤供給口107側と、薬剤攪拌部109側には、それぞれ保持部111、保持部112が設けられている。
 なお、本実施形態において、保持部111および保持部112は、外周平面部110に貫通孔を形成することによって構成される。
 また、本実施形態の薬剤容器101の攪拌子108は、棒磁石をテフロン(登録商標)などで封止したものが用いられている。また、その形状は、細長い円柱状のものが用いられている。
A holding part 111 and a holding part 112 are provided on the medicine supply port 107 side and the medicine stirring part 109 side in the outer peripheral flat part 110, respectively.
In the present embodiment, the holding part 111 and the holding part 112 are configured by forming a through hole in the outer peripheral plane part 110.
In addition, the stirrer 108 of the drug container 101 of the present embodiment uses a bar magnet sealed with Teflon (registered trademark) or the like. In addition, a long and narrow cylindrical shape is used.
 次に、本実施形態の薬剤容器101の使用方法に関して説明する。
 本実施形態では、製薬会社において製造された溶解液102や薬剤105が、製薬会社または薬剤封入工場において、溶解液102が薬剤収納室103に、また薬剤105が薬剤収納室106に、それぞれ封入(外気とは遮断された状態)される。
 そして、溶解液102と薬剤105が封入された状態で、薬剤容器101が病院に納品される。
Next, a method for using the drug container 101 of the present embodiment will be described.
In the present embodiment, the solution 102 and the drug 105 manufactured by the pharmaceutical company are sealed in the drug storage chamber 103 and the drug 105 in the drug storage chamber 106 in the drug company or the drug enclosure factory, respectively ( It is cut off from outside air).
Then, the drug container 101 is delivered to the hospital in a state where the dissolution liquid 102 and the drug 105 are sealed.
 薬剤容器101が納品された病院では、まず、患者に対して点滴を行う直前に、医療従事者(例えば、看護師)が、破断膜113を破断させると、薬剤収納室106内の薬剤105が薬剤供給路104を介して薬剤収納室103側に供給され、薬剤収納室103内において、溶解液102に薬剤105が溶解される。つまり、破断膜113は、外周平面部110を構成する二枚の平面体によって十分に薄い膜状となっているので、この部分に外部から力を付与することで、簡単に分離された状態を解除することができる。 In a hospital where the drug container 101 is delivered, first, when a medical worker (for example, a nurse) breaks the rupture film 113 immediately before instilling a patient, the drug 105 in the drug storage chamber 106 is removed. The medicine 105 is supplied to the medicine storage chamber 103 through the medicine supply path 104, and the medicine 105 is dissolved in the solution 102 in the medicine storage chamber 103. In other words, the rupture film 113 has a sufficiently thin film shape by the two planar bodies constituting the outer peripheral plane part 110, so that by applying a force from the outside to this part, a state of being easily separated can be obtained. It can be canceled.
 その後、医療従事者は、溶解液102と薬剤105とが溶解された薬剤を、患者に対して、点滴として投与することができる。
 ここで、本実施形態の薬剤容器101において、薬剤容器101内に収納された溶解液102と薬剤105とを溶解させる作業に関して、その詳細を説明する。
 図13は、薬剤容器101を、攪拌装置を用いて薬剤を溶解液に溶解させる動作を説明する概略図である。また、図14は、図13中の要部拡大正面図である。
Thereafter, the medical staff can administer the drug in which the solution 102 and the drug 105 are dissolved as an infusion to the patient.
Here, in the medicine container 101 of the present embodiment, the details of the work for dissolving the dissolving liquid 102 and the medicine 105 stored in the medicine container 101 will be described.
FIG. 13 is a schematic diagram for explaining the operation of dissolving the drug in the solution using the stirring device. FIG. 14 is an enlarged front view of a main part in FIG.
 本実施形態においては、上述したように、薬剤収納室106内の薬剤105が、薬剤供給路104を介して薬剤収納室103側に供給された状態で、薬剤攪拌部109を下側にして、薬剤容器101が、図13中に示す攪拌装置114にセットされる。
 その後、攪拌装置114によって、薬剤容器101内の薬剤攪拌部9内部に収納されている攪拌子108を回転させ、溶解液102と薬剤105とを溶解させる。
In the present embodiment, as described above, with the drug 105 in the drug storage chamber 106 being supplied to the drug storage chamber 103 via the drug supply path 104, the drug agitating unit 109 is on the lower side, The medicine container 101 is set in the stirring device 114 shown in FIG.
Thereafter, the stirrer 108 housed in the drug stirring unit 9 in the drug container 101 is rotated by the stirring device 114 to dissolve the solution 102 and the drug 105.
 本実施形態における攪拌装置114は、図13、図14に示すように、駆動部115を内蔵している。
 駆動部115上には、薬剤容器101の薬剤攪拌部109を置くための凹部116を有する筐体117が設けられている。筐体117上部には、薬剤容器101の薬剤攪拌部109の濁度を計測するための濁度計測部118が設けられている。
As shown in FIGS. 13 and 14, the stirring device 114 in the present embodiment incorporates a drive unit 115.
A housing 117 having a recess 116 for placing the medicine stirring part 109 of the medicine container 101 is provided on the driving part 115. A turbidity measuring unit 118 for measuring the turbidity of the drug stirring unit 109 of the drug container 101 is provided on the top of the casing 117.
 また、攪拌装置114は、薬剤105と溶解液102とを溶解する動作が完了した場合に動作完了を外部(例えば、医療従事者等)に報知する報知部119と、駆動部115と濁度計測部118と報知部119とが接続されており駆動部115および報知部119の動作を制御する制御部120と、を備えている。
 本実施形態では、駆動部115は、モータに接続された磁石を回転させる機構を有している。従って、駆動部115のモータが回転することによって、薬剤容器101内の攪拌子108も、それに追従するように回転させることができる。
In addition, the stirring device 114 includes a notification unit 119 for notifying the outside of the operation (for example, a medical worker, etc.) of the operation completion when the operation of dissolving the drug 105 and the solution 102 is completed, and the driving unit 115 and turbidity measurement. The control unit 120 is connected to the notification unit 119 and controls the operation of the driving unit 115 and the notification unit 119.
In the present embodiment, the drive unit 115 has a mechanism for rotating a magnet connected to a motor. Therefore, when the motor of the drive unit 115 rotates, the stirrer 108 in the medicine container 101 can also be rotated so as to follow it.
 なお、本実施形態では、薬剤容器101内の攪拌子108を配置している薬剤攪拌部109は、円筒状になるように形成されている(円筒容器で構成されている。)。これにより、より円滑に、薬剤攪拌部109内において、攪拌子108に回転動作を行わせることができる。
 また、本実施形態において、薬剤容器101の薬剤攪拌部109は、透明な材質で形成されている(透明容器で構成されている。)。これにより、攪拌装置114の濁度計測部118において、薬剤攪拌部109内部の溶解液102の濁度、すなわち溶解液102と薬剤105との溶解度合いを計測することができる。
In the present embodiment, the drug stirring unit 109 in which the stirring bar 108 in the drug container 101 is arranged is formed to be cylindrical (configured with a cylindrical container). Thereby, the stirring bar 108 can be rotated more smoothly in the drug stirring unit 109.
Moreover, in this embodiment, the chemical | medical agent stirring part 109 of the chemical | medical agent container 101 is formed with the transparent material (it is comprised with the transparent container). Thereby, the turbidity measuring unit 118 of the stirring device 114 can measure the turbidity of the solution 102 inside the drug stirring unit 109, that is, the degree of dissolution of the solution 102 and the drug 105.
 ここで、本実施形態における溶解液102と薬剤105とが収納された薬剤容器101を、攪拌装置114を用いて、薬剤105を溶解液102に自動的に溶解させる方法に関して説明する。
 図15は、本実施の形態に係る溶解液と薬剤とが収納された薬剤容器を、攪拌装置114を用いて、薬剤を溶解液に溶解させる動作を示すフローチャートを示すものである。
Here, a method for automatically dissolving the drug 105 in the solution 102 using the stirring device 114 will be described with respect to the drug container 101 storing the solution 102 and the drug 105 in the present embodiment.
FIG. 15 is a flowchart showing an operation of dissolving the drug in the solution using the stirring device 114 in the drug container storing the solution and the drug according to the present embodiment.
 まず、薬剤容器101の薬剤攪拌部109が、攪拌装置114の筐体117の凹部116内にセットされる(図15中のS1)。この時、保持部112に吊り下げ腕122を貫通させて、上方より保持された状態とする。
 次に、攪拌装置114の制御部120に、薬剤容器101に収納されている溶解液102、および薬剤105の種類と量が入力される(図15中のS2)。
First, the drug stirring unit 109 of the drug container 101 is set in the recess 116 of the casing 117 of the stirring device 114 (S1 in FIG. 15). At this time, the suspension arm 122 is passed through the holding portion 112 to be held from above.
Next, the type and amount of the solution 102 and the drug 105 stored in the drug container 101 are input to the control unit 120 of the stirring device 114 (S2 in FIG. 15).
 本実施形態では、予め、収納されている溶解液102と薬剤105の種類、量を含む情報が記録されたバーコードが、攪拌装置114に搭載されたバーコードリーダ(図示なし)によって読み込まれる。そして、バーコードリーダによって読み取られた情報は、制御部120に入力されることによって、溶解液102および薬剤105の種類と量とが入力される。 In this embodiment, a barcode on which information including the type and amount of the dissolved solution 102 and the medicine 105 stored in advance is read by a barcode reader (not shown) mounted on the stirring device 114. Then, the information read by the barcode reader is input to the control unit 120, whereby the types and amounts of the solution 102 and the drug 105 are input.
 次に、入力された溶解液102および薬剤105の種類・量に基づいて、攪拌子108を回転させる第1の回転数N1と、攪拌子108を回転させる第1の回転時間(T1)を決定する。
 次に、駆動部115の回転動作を開始させ、攪拌子108の回転数が第1の回転数(N1)になるように制御を行う(図15中のS3、第1の攪拌動作)。
Next, based on the inputted type and amount of the solution 102 and the medicine 105, the first rotation speed N1 for rotating the stirrer 108 and the first rotation time (T1) for rotating the stirrer 108 are determined. To do.
Next, the rotation operation of the drive unit 115 is started, and control is performed so that the rotation speed of the stirrer 108 becomes the first rotation speed (N1) (S3 in FIG. 15, first stirring operation).
 本実施形態では、予め、溶解液102および薬剤105の溶解実験を行い、薬剤105が溶解液102に十分に溶解するようにするための攪拌子108の回転数と回転数とを得ている。つまり、その溶解実験で得られた回転数と回転時間を、それぞれ第1の回転数N1と、第1の回転時間(T1)として、攪拌装置114の制御部120内部のメモリ(図示なし)に予め保管している。 In the present embodiment, the dissolution experiment of the dissolution liquid 102 and the drug 105 is performed in advance, and the rotation speed and rotation speed of the stirrer 108 for sufficiently dissolving the drug 105 in the dissolution liquid 102 are obtained. That is, the rotation speed and rotation time obtained in the dissolution experiment are respectively set as a first rotation speed N1 and a first rotation time (T1) in a memory (not shown) inside the control unit 120 of the stirring device 114. Stored in advance.
 よって、バーコードリーダによって読み取られた溶解液102および薬剤105の種類・量に基づいて、攪拌子108の回転させる第1の回転数N1と、攪拌子108の回転させる第1の回転時間(T1)とが設定される。
 次に、第1の攪拌動作が開始してからの時間(T)を計測し、第1の攪拌動作が開始してからの時間(T)が、前述の入力された第1の回転時間(T1)より経過したかどうか(T>T1)を判断する(図15中のS4)。
Therefore, based on the type / amount of the solution 102 and the drug 105 read by the barcode reader, the first rotation speed N1 for rotating the stirrer 108 and the first rotation time (T1) for rotating the stirrer 108 ) And are set.
Next, the time (T) from the start of the first stirring operation is measured, and the time (T) from the start of the first stirring operation is determined as the first rotation time ( It is determined whether or not T1) has elapsed (T> T1) (S4 in FIG. 15).
 ここで、T>T1となれば、次のステップに進む。一方、T<T1であれば、図15中のS3の第1の攪拌動作を継続する。
 なお、本実施形態においては、攪拌装置114の制御部120において、第1の攪拌動作が開始してからの時間(T)の計測と判断を行った。
 T>T1となった場合には、攪拌子108の回転数を低下させる(図15中のS5)。
If T> T1, the process proceeds to the next step. On the other hand, if T <T1, the first stirring operation in S3 in FIG. 15 is continued.
In the present embodiment, the control unit 120 of the stirring device 114 measures and determines the time (T) from the start of the first stirring operation.
When T> T1, the rotational speed of the stirrer 108 is decreased (S5 in FIG. 15).
 本実施形態では、S5において、第1の回転数N1の半分(0.5xN1)とした。また、本実施形態では、この動作は、攪拌装置114の制御部120によって行った。
 ここで、攪拌子108の回転数を低下させた理由は、薬剤攪拌部109内の渦121(図14参照)を小さくし、この渦121が、次のステップの濁度の計測に影響を与えないようにするためである。
In the present embodiment, in S5, the rotation speed is half of the first rotation speed N1 (0.5 × N1). In this embodiment, this operation is performed by the control unit 120 of the stirring device 114.
Here, the reason why the rotational speed of the stirrer 108 is decreased is that the vortex 121 (see FIG. 14) in the drug stirring unit 109 is reduced, and this vortex 121 affects the turbidity measurement in the next step. This is to prevent it from occurring.
 次に、溶解液102に薬剤105が完全に溶解されていることを確認するため、攪拌装置114の濁度計測部118において、薬剤攪拌部109内部の溶解液102の濁度を計測する(図15中のS6)。
 次に、薬剤攪拌部109内部の溶解液102の濁度が、所望の濁度以上になっているか否かを判断する(図15中のS7)。本実施形態では、この判断は、攪拌装置114の制御部120によって行われる。
Next, in order to confirm that the drug 105 is completely dissolved in the solution 102, the turbidity measuring unit 118 of the stirring device 114 measures the turbidity of the solution 102 inside the drug stirring unit 109 (FIG. S6 in 15).
Next, it is determined whether or not the turbidity of the solution 102 inside the drug stirring unit 109 is equal to or higher than a desired turbidity (S7 in FIG. 15). In the present embodiment, this determination is made by the control unit 120 of the stirring device 114.
 また、本実施形態においては、予め、溶解液102および薬剤105の溶解実験を行い、薬剤105が溶解液102に完全に溶解したときの濁度を計測し、その濁度を攪拌装置114の制御部120内部のメモリ(図示なし)に、所望の濁度として保管している。これにより、その保管された所望の濁度と、実際に計測された濁度を比較し、所望の濁度以上になっているか否かを判断する。 In this embodiment, a dissolution experiment of the dissolution liquid 102 and the drug 105 is performed in advance, the turbidity when the drug 105 is completely dissolved in the dissolution liquid 102 is measured, and the turbidity is controlled by the stirring device 114. The desired turbidity is stored in a memory (not shown) inside the unit 120. Thereby, the stored desired turbidity and the actually measured turbidity are compared to determine whether or not the desired turbidity is equal to or higher than the desired turbidity.
 ここで、薬剤攪拌部109内部の溶解液102の濁度が、所望の濁度以上になっている場合には、攪拌子108の回転を停止させる(図15中のS8)。
 その後、攪拌装置114の報知部119によって、攪拌装置114の外部に、溶解液102と薬剤105との溶解が完了したことを知らせる(図15中のS9)。なお、本実施形態では、報知部119として、表示灯を点灯させる形態が用いられている。
Here, when the turbidity of the solution 102 inside the medicine stirring unit 109 is equal to or higher than the desired turbidity, the rotation of the stirrer 108 is stopped (S8 in FIG. 15).
Thereafter, the notifying unit 119 of the stirrer 114 notifies the outside of the stirrer 114 that the dissolution of the dissolving liquid 102 and the drug 105 has been completed (S9 in FIG. 15). In the present embodiment, a form in which an indicator lamp is turned on is used as the notification unit 119.
 一方、薬剤攪拌部109内部の溶解液102の濁度が、所望の濁度以下の場合には、攪拌子108の回転させる第2の回転数N2と、攪拌子108の回転させる第2の回転時間(T2)とを決定すると共に、駆動部115の回転動作を開始させ、攪拌子108の回転数が第2の回転数(N2)になるように制御を行う(図15中のS10、第2の攪拌動作)。 On the other hand, when the turbidity of the solution 102 in the drug stirring unit 109 is equal to or lower than the desired turbidity, the second rotation speed N2 for rotating the stirrer 108 and the second rotation for rotating the stirrer 108 are performed. The time (T2) is determined, and the rotational operation of the drive unit 115 is started, and control is performed so that the rotational speed of the stirrer 108 becomes the second rotational speed (N2) (S10 in FIG. 2 stirring operation).
 なお、本実施形態では、第2の回転数N2としては、上記第1の回転数N1と同じ回転数が設定されており、第2の回転時間(T2)としては、5分が設定されている。
 次に、第2の攪拌動作が開始してからの時間(Ta)を計測し、第2の攪拌動作が開始してからの時間(Ta)が、入力された第2の回転時間(T2)を経過したか否か(Ta>T2)が判断される(図15中のS11)。
In the present embodiment, the second rotation speed N2 is set to the same rotation speed as the first rotation speed N1, and the second rotation time (T2) is set to 5 minutes. Yes.
Next, the time (Ta) from the start of the second stirring operation is measured, and the time (Ta) from the start of the second stirring operation is inputted as the second rotation time (T2). Is determined (Ta> T2) (S11 in FIG. 15).
 ここで、Ta>T2となった場合には、図15のS5(攪拌子108の回転数を低下させる)へ移行し、その後、薬剤攪拌部109内部の溶解液102の濁度を計測する。もし、Ta<T2となった場合には、第2の攪拌動作を継続させる(S11参照。)。すなわち、薬剤攪拌部109内部の溶解液102の濁度が所望の濁度以上になるまで、第2の攪拌動作を継続させる。 Here, when Ta> T2, the process proceeds to S5 in FIG. 15 (reducing the rotational speed of the stirrer 108), and then the turbidity of the solution 102 inside the drug stirring unit 109 is measured. If Ta <T2, the second stirring operation is continued (see S11). That is, the second stirring operation is continued until the turbidity of the solution 102 inside the drug stirring unit 109 becomes equal to or higher than the desired turbidity.
 なお、本実施形態では、薬剤105が溶解液102に溶け込むと、全体が濁った状態となる薬剤を用いていたが、薬剤105が溶解液102に溶け込むと透明感が増す薬剤を用いた場合には、濁度計測部118は、透明感を測定すればよい。
 以上のように、本実施形態によれば、薬剤収納室106内の薬剤105を、薬剤供給路104を介して、薬剤収納室103内の溶解液102に供給した後、薬剤攪拌部109に設けられた攪拌子108を回転させることで、薬剤105を溶解液102に自動的に溶解させることができる。この結果、従来よりも作業性の高い薬剤容器を提供することができる。
In the present embodiment, a drug is used that becomes cloudy when the drug 105 is dissolved in the solution 102. However, when a drug that increases transparency when the drug 105 is dissolved in the solution 102 is used. The turbidity measuring unit 118 may measure the transparency.
As described above, according to the present embodiment, the drug 105 in the drug storage chamber 106 is supplied to the solution 102 in the drug storage chamber 103 via the drug supply path 104 and then provided in the drug stirring unit 109. The drug 105 can be automatically dissolved in the dissolving liquid 102 by rotating the stirring bar 108. As a result, it is possible to provide a drug container with higher workability than before.
 特に、薬剤105が、例えば、がんの点滴治療に用いられる薬剤である場合、非常に毒性が高く、作業時に医療従事者自身が毒性に犯されてしてしまうおそれがある。
 本実施形態では、溶解液102は薬剤収納室103に、また薬剤105は薬剤収納室106に、それぞれ外気とは遮断された状態で収納されているとともに、混合時には破断膜113を破断させるだけで両者を混合させることができる。よって、医療従事者自身が薬剤の毒性に犯されてしてしまうことを防止することができる。
In particular, when the drug 105 is, for example, a drug used for instillation treatment of cancer, it is very toxic and there is a risk that the medical staff himself may be violated by toxicity during work.
In this embodiment, the solution 102 is stored in the drug storage chamber 103 and the drug 105 is stored in the drug storage chamber 106 in a state of being shielded from the outside air, and only the rupture film 113 is broken during mixing. Both can be mixed. Therefore, it is possible to prevent the medical staff from being violated by the toxicity of the medicine.
 そして、薬剤105を溶解液102に自動的に溶解させた後に、薬剤容器101が反転させられた状態で、点滴時活用の吊り下げ腕(図示せず)を保持部111に貫通させて保持される。次に、薬剤供給口107に点滴針(図示せず)を連結させ、その後、患者への点滴が行われる。
 (実施の形態10)
 図16は、本実施の形態に係る薬剤入り容器の正面図である。
Then, after the drug 105 is automatically dissolved in the dissolution liquid 102, the hanging arm (not shown) utilized during the drip is passed through the holding unit 111 and held in a state where the drug container 101 is inverted. The Next, an infusion needle (not shown) is connected to the medicine supply port 107, and then the patient is infused.
(Embodiment 10)
FIG. 16 is a front view of the medicine container according to the present embodiment.
 図16に示すように、薬剤収納室201,202,203は、それぞれ薬剤供給路204,204,204に連結されている。
 また、それぞれの薬剤供給路204,204,204における薬剤収納室201,202,203とは反対側には、単一の薬剤供給口205が設けられている。
 さらに、薬剤供給路204における薬剤収納室201,202,203が接続された部分には、開閉弁206が設けられている。
As shown in FIG. 16, the medicine storage chambers 201, 202, and 203 are connected to the medicine supply paths 204, 204, and 204, respectively.
Further, a single medicine supply port 205 is provided on the opposite side of each medicine supply path 204, 204, 204 from the medicine storage chambers 201, 202, 203.
Further, an opening / closing valve 206 is provided at a portion of the medicine supply path 204 to which the medicine storage chambers 201, 202, and 203 are connected.
 また、本実施形態では、開閉弁206が、開閉弁206の開閉状態を切り替えるハンドル207を有している。
 ハンドル207は、図16中の点線(1)から点線(5)の範囲にて反時計回りの一方向にのみ回転可能となっている。そして、ハンドル207は、点線(1)、点線(2)、点線(3)、点線(4)、点線(5)のそれぞれの位置において固定可能となっている。
In the present embodiment, the on-off valve 206 has a handle 207 that switches the open / close state of the on-off valve 206.
The handle 207 can be rotated only in one counterclockwise direction within a range from a dotted line (1) to a dotted line (5) in FIG. The handle 207 can be fixed at each position of the dotted line (1), the dotted line (2), the dotted line (3), the dotted line (4), and the dotted line (5).
 ここで、開閉弁206のハンドル207が、図16中の点線(1)から点線(5)のそれぞれの位置にあるときは、以下のような状態となっている。
・点線(1)の位置:薬剤収納室201,202,203のいずれにも接続されていない状態(閉状態)
・点線(2)の位置:薬剤収納室201と薬剤供給口205とが開状態
・点線(3)の位置:薬剤収納室202と薬剤供給口205とが開状態
・点線(4)の位置:薬剤収納室203と薬剤供給口205とが開状態
・点線(5)の位置:薬剤収納室201,202,203のいずれにも接続されていない状態(閉状態)
 つまり、本実施形態においては、開閉弁206のハンドル207を操作することによって、薬剤収納室201,202,203と薬剤供給口205との開閉状態を、以下(1)~(5)のように順次切り替えることができる。
(1)閉状態(図18のS101)
(2)1番目の薬剤収納室(すなわち薬剤収納室201)と薬剤供給口205が開状態(図18のS102)
(3)2番目の薬剤収納室(すなわち薬剤収納室202)と薬剤供給口205が開状態(図18のS103)
(4)3番目の薬剤収納室(すなわち薬剤収納室203)と薬剤供給口205が開状態(図18のS104)
(5)閉状態(図18のS105)
 なお、本実施形態における薬剤収納室201,202,203は、可撓性を有する円筒形状の部材が用いられている。また、本実施形態においては、薬剤収納室201,202,203は、それぞれの表裏面は、可撓性で透明のカバー208で覆われている。そして、カバー208の第1端側における外側には、薬剤供給口205が設けられていると共に、カバー208の第1端側には、薬剤調整時吊り下げ孔209が設けられている。また、カバー208における第1端とは反対側の第2端側には、薬剤投与時吊り下げ孔210が設けられている。
Here, when the handle 207 of the on-off valve 206 is located at each position from the dotted line (1) to the dotted line (5) in FIG.
-Position of dotted line (1): state not connected to any of medicine storage chambers 201, 202, 203 (closed state)
The position of the dotted line (2): the medicine storage chamber 201 and the medicine supply port 205 are open. The position of the dotted line (3): The medicine storage chamber 202 and the medicine supply port 205 are open. The position of the dotted line (4): The medicine storage chamber 203 and the medicine supply port 205 are in an open state / dotted line (5) position: not connected to any of the medicine storage chambers 201, 202, 203 (closed state)
In other words, in the present embodiment, by operating the handle 207 of the on-off valve 206, the open / close state of the medicine storage chambers 201, 202, 203 and the medicine supply port 205 is changed as follows (1) to (5). It can be switched sequentially.
(1) Closed state (S101 in FIG. 18)
(2) First drug storage chamber (that is, drug storage chamber 201) and drug supply port 205 are open (S102 in FIG. 18).
(3) The second medicine storage chamber (that is, the medicine storage chamber 202) and the medicine supply port 205 are open (S103 in FIG. 18).
(4) The third medicine storage chamber (that is, the medicine storage chamber 203) and the medicine supply port 205 are open (S104 in FIG. 18).
(5) Closed state (S105 in FIG. 18)
In the present embodiment, the medicine storage chambers 201, 202, and 203 are made of flexible cylindrical members. In the present embodiment, the medicine storage chambers 201, 202, and 203 are each covered with a flexible and transparent cover 208 on the front and back surfaces. A drug supply port 205 is provided on the outer side of the cover 208 on the first end side, and a hanging hole 209 for adjusting the drug is provided on the first end side of the cover 208. In addition, a suspension hole 210 for drug administration is provided on the second end side of the cover 208 opposite to the first end.
 次に、本実施形態の薬剤容器の使用方法について説明する。
 本実施形態においては、薬剤容器が薬剤供給口205(すなわち、薬剤調整時吊り下げ孔209)が上部に来るような向きとされ、製薬会社で製造された薬剤が、製薬会社または薬剤封入工場において、薬剤供給口205から薬剤収納室201,202,203内に収納される。
Next, the usage method of the chemical | medical agent container of this embodiment is demonstrated.
In the present embodiment, the medicine container is oriented so that the medicine supply port 205 (that is, the hanging hole 209 at the time of medicine adjustment) comes to the top, and the medicine manufactured by the pharmaceutical company is used in the pharmaceutical company or the medicine enclosure factory. From the medicine supply port 205, the medicine is stored in the medicine storage chambers 201, 202, 203.
 本実施形態においては、薬剤収納室201,202,203内に収納される薬剤を、それぞれ薬剤211,212,213とする。
 薬剤211,212,213が、それぞれ薬剤収納室201,202,203内に供給された後、薬剤供給口205は閉状態となっている。このため、薬剤211,212,213が、それぞれ薬剤収納室201,202,203内に封入された状態となる。
In the present embodiment, the drugs stored in the drug storage chambers 201, 202, and 203 are referred to as drugs 211, 212, and 213, respectively.
After the drugs 211, 212, and 213 are supplied into the drug storage chambers 201, 202, and 203, respectively, the drug supply port 205 is closed. Therefore, the medicines 211, 212, and 213 are sealed in the medicine storage chambers 201, 202, and 203, respectively.
 薬剤容器は、この封入状態のまま薬剤入り薬剤容器として病院に納品される。なお、この封入状態において、薬剤入り薬剤容器の開閉弁206のハンドル7は、上述した点線(1)の位置(薬剤収納室201,202,203のいずれにも接続されていない状態(閉状態)(図17(a)参照))に位置している。
 次に、納品を受けた病院では、薬剤収納室202内において、薬剤219と薬剤212とを混合させる作業を行う(図17(b)参照)。
The drug container is delivered to the hospital as a drug-containing drug container in this sealed state. In this sealed state, the handle 7 of the opening / closing valve 206 of the medicine container containing the medicine is not connected to any of the above-described dotted line (1) (the medicine storage chambers 201, 202, 203 are in the closed state). (See FIG. 17A)).
Next, in the hospital which has received the delivery, the medicine 219 and the medicine 212 are mixed in the medicine storage chamber 202 (see FIG. 17B).
 次に、吸引部材を用いて、薬剤収納室202内において混合された薬剤の投薬量の調整が行われる(図17(c)参照)。
 次に、患者に対し、次のようにして点滴が行われる。
 図16に示すように、薬剤投与時吊り下げ孔210側が上部に来るようにして、フック(図示なし)を薬剤投与時吊り下げ孔210に挿入して、薬剤容器を吊り下げる。
Next, the dosage of the medicine mixed in the medicine storage chamber 202 is adjusted using the suction member (see FIG. 17C).
Next, the patient is infused as follows.
As shown in FIG. 16, the drug container is suspended by inserting a hook (not shown) into the suspension hole 210 at the time of drug administration so that the suspension hole 210 side at the time of drug administration is at the top.
 次に、薬剤供給口205にチューブ(図示なし)を介して、点滴針(図示なし)を連結し、この状態で、点滴針が患者に差し込まれる。
 その後、開閉弁206のハンドル207を反時計回りに回転させ、上述した点線(2)の位置(薬剤収納室201と薬剤供給口205とが開状態)に位置させる。この状態において、点滴針から、薬剤収納室201に収納されている薬剤211が、患者に投与される(図17(d)参照)。
Next, an infusion needle (not shown) is connected to the medicine supply port 205 via a tube (not shown), and in this state, the infusion needle is inserted into the patient.
Thereafter, the handle 207 of the on-off valve 206 is rotated counterclockwise to the position indicated by the dotted line (2) (the medicine storage chamber 201 and the medicine supply port 205 are in the open state). In this state, the medicine 211 stored in the medicine storage chamber 201 is administered to the patient from the drip needle (see FIG. 17D).
 次に、薬剤211の投与が完了すると、開閉弁206のハンドル207を反時計回りに回転させ、上述した点線(3)の位置(薬剤収納室202と薬剤供給口205とが開状態)に位置させる。この状態において、点滴針から、薬剤収納室202に収納されている薬剤212が、患者に投与される(図17(e)参照)。
 さらに、薬剤212の投与が完了すると、開閉弁206のハンドル7を反時計回りに回転させ、上述した点線(4)の位置(薬剤収納室203と薬剤供給口205とが開状態)に位置させる。この状態において、点滴針から、薬剤収納室203に収納されている薬剤213が、患者に投与される(図17(f)参照)。
Next, when the administration of the medicine 211 is completed, the handle 207 of the on-off valve 206 is rotated counterclockwise to the position of the dotted line (3) described above (the medicine storage chamber 202 and the medicine supply port 205 are in the open state). Let In this state, the medicine 212 stored in the medicine storage chamber 202 is administered to the patient from the drip needle (see FIG. 17 (e)).
Further, when the administration of the medicine 212 is completed, the handle 7 of the on-off valve 206 is rotated counterclockwise so as to be located at the position indicated by the dotted line (4) (the medicine storage chamber 203 and the medicine supply port 205 are open). . In this state, the medicine 213 stored in the medicine storage chamber 203 is administered to the patient from the drip needle (see FIG. 17 (f)).
 次に、薬剤212の投与が完了、すなわち、薬剤入り薬剤容器に収納された全ての薬剤(本実施形態では、薬剤211,212,213)の投与が完了すると、開閉弁206のハンドル207を反時計回りに回転させ、上述した点線(5)の位置(薬剤収納室201,202,203のいずれにも接続されていない状態(閉状態))に位置させた後、点滴針が患者から抜かれる。 Next, when the administration of the medicine 212 is completed, that is, when the administration of all the medicines stored in the medicine container containing the medicine (the medicines 211, 212, and 213 in this embodiment) is completed, the handle 207 of the on-off valve 206 is turned over. After rotating clockwise, the drip needle is removed from the patient after being positioned at the position of the dotted line (5) described above (not connected to any of the medicine storage chambers 201, 202, 203 (closed state)). .
 上述の説明で明らかなように、本実施形態においては、薬剤が外部へ曝露してしまう原因の1つである点滴治療準備時における複数のチューブ接続を行う必要がない。このため、点滴治療準備時の薬剤の暴露することがなく、結果として、これらを取り扱う医療従事者への安全性を更に高めることができる。
 例えば、薬剤211を生理食塩水、薬剤212を抗がん剤、薬剤213を生理食塩水とし、がん治療の点滴に用いる薬剤容器であった場合は、抗がん剤の暴露は避ければならないものもある。
As is apparent from the above description, in the present embodiment, it is not necessary to perform a plurality of tube connections at the time of preparation for infusion treatment, which is one of the causes that the medicine is exposed to the outside. For this reason, there is no exposure of the medicine at the time of preparation for the drip treatment, and as a result, it is possible to further improve the safety for the medical staff handling these.
For example, if the drug 211 is a physiological saline, the drug 212 is an anticancer drug, the drug 213 is a physiological saline, and the drug container is used for infusion of cancer treatment, exposure of the anticancer drug must be avoided. There are also things.
 ただし、本実施形態では、薬剤容器内部の開閉弁206の切り替え動作だけで、投与薬剤の切り替え作業を行うことができる。これにより、取り扱いが極めて簡便で、かつ医療従事者への安全性を更に高めることができる。
 なお、本実施形態においては、3種類の薬剤211,212,213を患者に投与可能な薬剤容器の一例を開示したが、本発明はこれに限定されるものではない。
However, in this embodiment, the switching operation of the administration medicine can be performed only by the switching operation of the on-off valve 206 inside the medicine container. Thereby, handling is very simple and the safety | security to a medical worker can further be improved.
In addition, in this embodiment, although an example of the chemical | medical agent container which can administer three types of chemical | medical agents 211,212,213 to a patient was disclosed, this invention is not limited to this.
 例えば、N種類の薬剤を収納するN個の薬剤収納室と、そのN個の薬剤収納室に設けられた薬剤供給路と、その薬剤供給路が接続された開閉弁とを備えた薬剤容器に対して、本発明を適用してもよい。
 この場合には、開閉弁は、以下(1)~(5)の順番にて、それぞれの薬剤収納室201,202,203と薬剤供給口との開閉状態を切り替えることができる。これにより、多種類の種類の薬剤を患者に投与可能な薬剤容器を提供することができる。
(1)閉状態
(2)1番目の薬剤収納室と前記薬剤供給口が開状態
(3)2番目の薬剤収納室と前記薬剤供給口が開状態
(4)N(ここで、Nは2以上の自然数)番目の薬剤収納室と前記薬剤供給口が開状態
(5)閉状態
 さらに本実施形態においては、3種類の薬剤を開閉弁206で5段階に切り替える薬剤容器の一例を開示したが、本発明はこれに限定されるものではない。
For example, in a medicine container provided with N medicine storage chambers for storing N kinds of medicines, a medicine supply path provided in the N medicine storage rooms, and an on-off valve connected to the medicine supply path. On the other hand, the present invention may be applied.
In this case, the on-off valve can switch the open / close state between the respective drug storage chambers 201, 202, 203 and the drug supply port in the order of (1) to (5) below. Thereby, a medicine container which can administer many kinds of medicines to a patient can be provided.
(1) Closed state (2) First drug storage chamber and drug supply port open state (3) Second drug storage chamber and drug supply port open state (4) N (where N is 2 (Natural number) The medicine storage chamber and the medicine supply port are in the open state (5) in the closed state. Further, in the present embodiment, an example of the medicine container in which three kinds of medicines are switched in five stages by the opening / closing valve 206 is disclosed. However, the present invention is not limited to this.
 例えば、薬剤211を生理食塩水、薬剤212を抗がん剤、薬剤213を生理食塩水とし、その生理食塩水が薬剤供給口205まで連通していた場合には、接続作業で医療従事者が生理食塩水に曝露したとしても無害である。よって、開閉弁205が閉状態になる最初と最後の順番を省略し、以下(1)~(3)の順番にて、それぞれの薬剤収納室と薬剤供給口との開閉状態を切り替えるよう3つの順番に簡略化することもできる。
(1)1番目の薬剤収納室(すなわち薬剤収納室201)と薬剤供給口205が開状態
(2)2番目の薬剤収納室(すなわち薬剤収納室202)と薬剤供給口205が開状態
(3)3番目の薬剤収納室(すなわち薬剤収納室203)と薬剤供給口205が開状態
 また、本実施形態においては、開閉弁206のハンドル7を、一定方向にのみ回転する(本実施形態においては反時計回り)構成としている。
For example, when the medicine 211 is a physiological saline, the medicine 212 is an anticancer agent, the medicine 213 is a physiological saline, and the physiological saline communicates with the medicine supply port 205, a medical worker can perform a connection operation. Harmless even if exposed to saline. Therefore, the first and last order in which the on-off valve 205 is closed is omitted, and the three open / close states of each medicine storage chamber and medicine supply port are switched in the order of (1) to (3) below. It can also be simplified in order.
(1) First drug storage chamber (ie, drug storage chamber 201) and drug supply port 205 are open (2) Second drug storage chamber (ie, drug storage chamber 202) and drug supply port 205 are open (3 ) The third medicine storage chamber (that is, the medicine storage chamber 203) and the medicine supply port 205 are open. In this embodiment, the handle 7 of the on-off valve 206 is rotated only in a certain direction (in this embodiment, Counterclockwise).
 これにより、薬剤容器を取り扱う医療従事者が、誤って開閉弁206のハンドル207を回転させることを未然に防止することができる。その結果、医療事故の発生をより確実に防止することができる。
 なお、上記実施の形態1~3、5~8の構成では、開閉弁を閉じた後も若干の時間だけ吸引を続けることで、薬剤調整室内を陰圧に保つことができる。このため、投薬後に容器を保管する間や廃棄時において、薬剤が漏出しにくくできる安全上のメリットがある。
As a result, it is possible to prevent a medical worker handling the medicine container from rotating the handle 207 of the on-off valve 206 by mistake. As a result, the occurrence of a medical accident can be prevented more reliably.
In the configurations of the first to third embodiments and the fifth to eighth embodiments, the negative pressure can be maintained in the medicine adjustment chamber by continuing the suction for some time after the on-off valve is closed. For this reason, there is a safety merit that the medicine is difficult to leak out during storage of the container after medication or at the time of disposal.
 本発明においては、患者の体格や年齢等によって異なる個人毎に必要とする薬剤量の調整を、開閉弁を開放して一部の薬剤を薬剤調整室に移動させることで行うことができるため、従来よりも作業性を向上させることができるという効果を奏することから、薬剤容器、および薬剤を封入した薬剤入り容器として広く活用が期待される。 In the present invention, it is possible to adjust the amount of drug required for each individual different depending on the patient's physique, age, etc., by opening the on-off valve and moving some drugs to the drug adjustment room, Since it has an effect that workability can be improved as compared with the conventional case, it is expected to be widely used as a medicine container and a medicine container containing a medicine.
 1   薬剤収納室
 2   薬剤供給口
 3   薬剤調整路
 4   薬剤調整室
 5   吸引口
 6   開閉弁
 7   調整目盛り
 8   カバー
 9   薬剤調整時吊り下げ孔
10   薬剤投与時吊り下げ孔
11   薬剤
12   フック
13   注射器
14   吸引器
15   チューブ
16   点滴針
17   破断膜
18   副薬剤収納室
19   薬剤
20   薬剤
21   破断膜
22   副薬剤収納室
23   薬剤
24   副開閉弁
25   副薬剤収納室
26   薬剤
27   吸引部材
28   破断膜
29   副薬剤収納室
30   薬剤
31   気液分離膜
32   薬剤投与目盛り
33   逆止め弁
101   薬剤容器
102   溶解液
103   薬剤収納室
104   薬剤供給路
105   薬剤
106   薬剤収納室
107   薬剤供給口
108   攪拌子
109   薬剤攪拌部
110   外周平面部
111,112 保持部
113   破断膜
114   攪拌装置
115   駆動部
116   凹部
117   筐体
118   濁度計測部
119   報知部
120   制御部
121   渦
122   吊り下げ腕
201,202,203 薬剤収納室
204   薬剤供給路
205   薬剤供給口
206   開閉弁
207   ハンドル
208   カバー
209   薬剤調整時吊り下げ孔
210 薬剤投与時吊り下げ孔
211,212,213 薬剤
DESCRIPTION OF SYMBOLS 1 Drug storage chamber 2 Drug supply port 3 Drug adjustment path 4 Drug adjustment chamber 5 Suction port 6 On-off valve 7 Adjustment scale 8 Cover 9 Hanging hole at the time of drug adjustment 10 Hanging hole at the time of drug administration 11 Drug 12 Hook 13 Syringe 14 Suction device 15 Tube 16 Infusion Needle 17 Breaking Film 18 Secondary Drug Storage Chamber 19 Drug 20 Drug 21 Breaking Film 22 Secondary Drug Storage Chamber 23 Drug 24 Secondary Opening Valve 25 Secondary Drug Storage Chamber 26 Drug 27 Suction Member 28 Breaking Film 29 Secondary Drug Storage Chamber 30 Drug 31 Gas-liquid separation membrane 32 Drug administration scale 33 Check valve 101 Drug container 102 Dissolved solution 103 Drug storage chamber 104 Drug supply path 105 Drug 106 Drug storage chamber 107 Drug supply port 108 Stirrer 109 Drug stirring section 110 Outer peripheral plane section 111 112 Holding part 113 Breaking film 11 Stirrer 115 Drive unit 116 Recess 117 Housing 118 Turbidity measurement unit 119 Notification unit 120 Control unit 121 Vortex 122 Hanging arms 201, 202, 203 Drug storage chamber 204 Drug supply path 205 Drug supply port 206 Opening / closing valve 207 Handle 208 Cover 209 Hanging hole 210 during drug adjustment Hanging hole 211, 212, 213 during drug administration

Claims (27)

  1.  薬剤供給口を有する薬剤収納室と、
     前記薬剤収納室に貯留された薬剤の調整を行うとともに、定形性を有する薬剤調整室と、
     前記薬剤収納室と前記薬剤調整室とを連結する薬剤調整路と、
     前記薬剤調整室に連結された吸引口と、
    前記薬剤調整路に設けられた開閉弁と、
    を備えた薬剤容器。
    A medicine storage chamber having a medicine supply port;
    While adjusting the drug stored in the drug storage chamber, a drug adjustment chamber having a fixed form,
    A drug adjustment path connecting the drug storage chamber and the drug adjustment chamber;
    A suction port connected to the drug adjustment chamber;
    An on-off valve provided in the medicine adjustment path;
    Drug container with.
  2.  前記吸引口には、吸引部材が連結される、
    請求項1に記載の薬剤容器。
    A suction member is connected to the suction port.
    The drug container according to claim 1.
  3.  薬剤収納室は可撓性を有する、
    請求項1または2に記載の薬剤容器。
    The medicine storage room has flexibility,
    The medicine container according to claim 1 or 2.
  4.  薬剤調整室は、前記薬剤の量を計るための調整目盛りを有している、
    請求項3に記載の薬剤容器。
    The medicine adjustment room has an adjustment scale for measuring the amount of the medicine,
    The drug container according to claim 3.
  5.  前記薬剤収納室と前記薬剤調整室とを覆う可撓性のカバーと、
     前記カバーの一端側外に設けられた薬剤供給口と、
     前記カバーの一端側に設けられた薬剤調整時吊り下げ孔と、
     前記カバーの他端側に設けられた薬剤投与時吊り下げ孔と、
    をさらに備えている、
    請求項1から4のいずれか1つに記載の薬剤容器。
    A flexible cover that covers the medicine storage chamber and the medicine adjustment chamber;
    A medicine supply port provided outside one end of the cover;
    A hanging hole for adjusting the medicine provided on one end side of the cover,
    A hanging hole for drug administration provided on the other end side of the cover,
    Further equipped with,
    The medicine container according to any one of claims 1 to 4.
  6.  前記吸引口は、前記カバー外に設けられている、
    請求項5に記載の薬剤容器。
    The suction port is provided outside the cover,
    The drug container according to claim 5.
  7.  副薬剤収納室と、
     前記薬剤収納室と前記副薬剤収納室とを連通させる第1の連通部と、
    をさらに備えている、
    請求項1から6のいずれか1つに記載の薬剤容器。
    An auxiliary medicine storage room,
    A first communication portion for communicating the medicine storage chamber and the auxiliary medicine storage chamber;
    Further equipped with,
    The medicine container according to any one of claims 1 to 6.
  8.  前記第1の連通部は、前記薬剤収納室と前記副薬剤収納室との間に設けられた破断膜を含む、請求項7に記載の薬剤容器。 The drug container according to claim 7, wherein the first communication part includes a rupture film provided between the drug storage chamber and the sub-drug storage chamber.
  9.  前記第1の連通部は、前記薬剤調整室と前記副薬剤収納室間に設けられた副開閉弁を含む、請求項7に記載の薬剤容器。 The drug container according to claim 7, wherein the first communication part includes a sub open / close valve provided between the drug adjustment chamber and the sub drug storage chamber.
  10.  副薬剤収納室と、
     前記薬剤収納室と前記副薬剤収納室とを連通させる第2の連通部と、
    をさらに備えている、
    請求項1に記載の薬剤容器。
    An auxiliary medicine storage room,
    A second communication portion for communicating the medicine storage chamber and the auxiliary medicine storage chamber;
    Further equipped with,
    The drug container according to claim 1.
  11.  前記第2の連通部は、前記薬剤調整室と前記副薬剤収納室との間に設けられた破断膜を含む、
    請求項10に記載の薬剤容器。
    The second communication portion includes a rupture film provided between the drug adjustment chamber and the auxiliary drug storage chamber.
    The drug container according to claim 10.
  12.  前記副薬剤収納室に収納された薬剤は、薬剤収納室に収納された薬剤を中和する中和剤、もしくは前記薬剤収納室に収納された薬剤を無毒化する失効剤である、
    請求項10または11に記載の薬剤容器。
    The drug stored in the auxiliary drug storage chamber is a neutralizing agent that neutralizes the drug stored in the drug storage chamber, or a deactivating agent that detoxifies the drug stored in the drug storage chamber.
    The medicine container according to claim 10 or 11.
  13.  前記薬剤調整室と吸引口との間に設けられた気液分離膜を、さらに備えている、
    請求項1に記載の薬剤容器。
    A gas-liquid separation membrane provided between the drug adjustment chamber and the suction port,
    The drug container according to claim 1.
  14.  前記薬剤調整室は、前記薬剤収納室に収納された薬剤の量を示すために設けられた薬剤投与目盛りを有している、
    請求項1に記載の薬剤容器。
    The drug adjustment chamber has a drug administration scale provided to indicate the amount of drug stored in the drug storage chamber.
    The drug container according to claim 1.
  15.  請求項1から14のいずれか1つに記載の薬剤容器と、
     前記薬剤容器の前記薬剤収納室内に貯留された薬剤と、
    を備えた薬剤入り容器。
    A drug container according to any one of claims 1 to 14,
    A drug stored in the drug storage chamber of the drug container;
    A container with a medicine.
  16.  前記薬剤は、がん治療薬を含む、
    請求項15に記載の薬剤入り容器。
    The medicament includes a cancer therapeutic agent,
    The medicine container according to claim 15.
  17.  溶解液を収納した薬剤調整室と、
     前記薬剤調整室に薬剤供給路を介して連結されると共に、薬剤を収納した薬剤収納室と、
     前記薬剤調整室に連結された薬剤投与口と、
     前記薬剤調整室に連結されると共に、その内部に攪拌子を収納可能な薬剤攪拌部と、
    を備えた薬剤容器。
    A drug adjustment chamber containing a solution,
    A drug storage chamber that is connected to the drug adjustment chamber via a drug supply path and stores a drug,
    A drug administration port connected to the drug adjustment chamber;
    A drug stirring unit that is connected to the drug adjusting chamber and can store a stirring bar therein,
    Drug container with.
  18.  前記薬剤攪拌部は、前記薬剤調整室側が開口した容器である、
    請求項17に記載の薬剤容器。
    The drug stirring unit is a container opened on the drug adjustment chamber side.
    The drug container according to claim 17.
  19.  前記薬剤攪拌部は、円筒状容器である、
    請求項18に記載の薬剤容器。
    The drug stirring unit is a cylindrical container.
    The drug container according to claim 18.
  20.  前記容器は、透明である、
    請求項18または19に記載の薬剤容器。
    The container is transparent;
    The medicine container according to claim 18 or 19.
  21.  前記薬剤攪拌部は、前記薬剤調整室の薬剤投与口とは反対側に設けられている、
    請求項17から20のいずれかに記載の薬剤容器。
    The drug stirring unit is provided on the side opposite to the drug administration port of the drug adjustment chamber,
    The drug container according to any one of claims 17 to 20.
  22.  前記薬剤調整室の外周部分に設けられた外周平面部と、
     前記外周平面部における前記薬剤投与口側と前記薬剤攪拌部側とに設けられた保持部と、
    をさらに備えている、
    請求項21に記載の薬剤容器。
    An outer peripheral flat surface provided in an outer peripheral portion of the medicine adjustment chamber;
    A holding part provided on the drug administration port side and the drug stirring part side in the outer peripheral plane part,
    Further equipped with,
    The drug container according to claim 21.
  23.  前記保持部は、前記外周平面部に設けられた貫通孔である、
    請求項22に記載の薬剤容器。
    The holding portion is a through hole provided in the outer peripheral plane portion.
    The drug container according to claim 22.
  24.  前記薬剤収納室は、前記外周平面部に設けられている、
    請求項22または23に記載の薬剤容器。
    The medicine storage chamber is provided in the outer peripheral plane portion.
    24. A drug container according to claim 22 or 23.
  25.  前記薬剤収納室に収納された薬剤は、がん治療薬である、
    請求項17から24のいずれかに記載の薬剤容器。
    The drug stored in the drug storage room is a cancer drug.
    The medicine container according to any one of claims 17 to 24.
  26.  複数の薬剤収納室と、前記複数の薬剤収納室の各々に連結された複数の薬剤供給路と、前記複数の薬剤供給路に、開閉弁を介して接続された薬剤供給口と、を備えた薬剤容器の使用方法であって、
     前記開閉弁は、以下(1)~(5)の順番にて、それぞれの前記薬剤収納室と前記薬剤供給口との開閉状態を切り替える薬剤容器の使用方法。
    (1)閉状態
    (2)1番目の薬剤収納室と前記薬剤供給口が開状態
    (3)2番目の薬剤収納室と前記薬剤供給口が開状態
    (4)N(ここで、Nは2以上の自然数)番目の薬剤収納室と前記薬剤供給口が開状態
    (5)閉状態
    A plurality of medicine storage chambers, a plurality of medicine supply passages connected to each of the plurality of medicine storage chambers, and a medicine supply port connected to the plurality of medicine supply passages via an on-off valve. A method of using a drug container,
    The on-off valve is a method of using a medicine container that switches between opening and closing states of the medicine storage chamber and the medicine supply port in the order of (1) to (5) below.
    (1) Closed state (2) First drug storage chamber and drug supply port open state (3) Second drug storage chamber and drug supply port open state (4) N (where N is 2 (Natural number) The drug storage chamber and the drug supply port are open (5) closed
  27.  前記開閉弁は、一定方向にのみ回転させることによって、前記開閉状態を切り替える、
    請求項26に記載の薬剤容器の使用方法。
    The on-off valve switches the on-off state by rotating only in a certain direction.
    27. A method of using the drug container according to claim 26.
PCT/JP2012/006203 2011-10-18 2012-09-27 Drug container, and drug-filled container in which drug is sealed therein WO2013057883A1 (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
JP2011-228600 2011-10-18
JP2011228600 2011-10-18
JP2011-269709 2011-12-09
JP2011269709A JP2015002752A (en) 2011-12-09 2011-12-09 Drug container
JP2011278118A JP2015002754A (en) 2011-10-18 2011-12-20 Drug container
JP2011-278118 2011-12-20
JP2011278117A JP2015002753A (en) 2011-10-18 2011-12-20 Drug container, and drug-containing container encapsulating drug
JP2011-278117 2011-12-20

Publications (1)

Publication Number Publication Date
WO2013057883A1 true WO2013057883A1 (en) 2013-04-25

Family

ID=48140553

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2012/006203 WO2013057883A1 (en) 2011-10-18 2012-09-27 Drug container, and drug-filled container in which drug is sealed therein

Country Status (1)

Country Link
WO (1) WO2013057883A1 (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03112562A (en) * 1989-09-27 1991-05-14 Terumo Corp Blood bag
JPH06509263A (en) * 1992-05-16 1994-10-20 コニーツコ・アルブレヒト Threaded containers as supply containers for pharmaceutical and/or cosmetic liniments that can be made with a stirrer
JPH08257099A (en) * 1995-03-20 1996-10-08 Material Eng Tech Lab Inc Medical vessel
JPH0947488A (en) * 1995-05-26 1997-02-18 Material Eng Tech Lab Inc Medical container
JPH10309304A (en) * 1997-05-12 1998-11-24 Terumo Corp Multicell container
JPH11503926A (en) * 1995-01-20 1999-04-06 ローランド・バイヤード・ウィルソン・ジュニア Mutual demixing prevention valve and fluid supply system using the same
JP2003518963A (en) * 1999-11-05 2003-06-17 タンデム メディカル、インコーポレイテッド Intravenous infusion drug delivery device and method

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03112562A (en) * 1989-09-27 1991-05-14 Terumo Corp Blood bag
JPH06509263A (en) * 1992-05-16 1994-10-20 コニーツコ・アルブレヒト Threaded containers as supply containers for pharmaceutical and/or cosmetic liniments that can be made with a stirrer
JPH11503926A (en) * 1995-01-20 1999-04-06 ローランド・バイヤード・ウィルソン・ジュニア Mutual demixing prevention valve and fluid supply system using the same
JPH08257099A (en) * 1995-03-20 1996-10-08 Material Eng Tech Lab Inc Medical vessel
JPH0947488A (en) * 1995-05-26 1997-02-18 Material Eng Tech Lab Inc Medical container
JPH10309304A (en) * 1997-05-12 1998-11-24 Terumo Corp Multicell container
JP2003518963A (en) * 1999-11-05 2003-06-17 タンデム メディカル、インコーポレイテッド Intravenous infusion drug delivery device and method

Similar Documents

Publication Publication Date Title
JP4291506B2 (en) Intravenous drug mixing and injection system, method and cassette
US7785312B2 (en) Convenience IV kits and methods of use
US6953450B2 (en) Apparatus and method for administration of IV liquid medication and IV flush solutions
JP5953488B2 (en) Container, system and method for providing a solution
ES2384193T5 (en) Apparatus for the automatic preparation of a medicine and corresponding preparation procedure
JP5062639B2 (en) Transfer system for forming a drug solution from a lyophilized drug
US20100022953A1 (en) Medication delivery devices having penetrable sterility barriers and alignment features
US20100204659A1 (en) Medication delivery system
TWI558425B (en) Tubing set having a gate for the connection of vials and hemodialysis system
AU2320199A (en) Medication delivery apparatus
JPH11503627A (en) Fluid device
EP3195845A1 (en) Pharmacy bag with integrated flush option
JP2004166847A (en) Drip preparation apparatus, mixing tube, liquid medicine receptacle, liquid mixture receptacle, drip preparation system, and preparation method for drip
BR102019006389B1 (en) STERILE FLEXIBLE PACKAGING WITH PRESSURE COMPENSATOR FOR THE DOSED RECONSTITUTION OF FLUID MEDICINAL AND NUTRITIONAL SUBSTANCES TO BE ADMINISTERED TO PATIENTS BY INFUSION OR INJECTION
JP2009532112A (en) Fluid delivery system with bulk container and pump assembly
WO2013001525A1 (en) Flow control device for reconstitution and administration of liquid drug dosage, and single use kit and medical apparatus for use therewith
JP2015002752A (en) Drug container
WO2013057883A1 (en) Drug container, and drug-filled container in which drug is sealed therein
KR102172525B1 (en) Injection preparing kit and injection preparing system including the same
JP7431424B2 (en) cylinder pump
WO2023196297A2 (en) System for on-demand manufacturing of parenteral solutions
KR20230058943A (en) Injection preparing device
EP3881875A1 (en) Delivery device for delivering a drug
JP2015002753A (en) Drug container, and drug-containing container encapsulating drug
CN116942526A (en) Sterile dispensing system and dispensing method

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12842350

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12842350

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP